rfhg_140678.1

Basic information about the TSS

---

TSS ID: rfhg_140678.1 Species: human Chr: chr11		Start: 72041978 End: 72041997 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D2466915,EH38E1550475)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000543009.5:-145 GeneID: 4926 HGNC/MGI_ID: HGNC:8059 UniProt_ID: F5H3L6 Nearer transcript ids and distances: ENST00000537930.5:186 ENST00000544238.5:453 view more...

Gene_name: nuclear mitotic apparatus protein 1 Gene_symbol: NUMA1 Gene_synonyms: NUMA Gene_source: HGNC:8059

TATA-Box annotation

---

Distance to TSS:	27696
Nearest PromoterID:	NR_104178
Entrez ID:	100128494
Nearest Unigene:	Hs.713607
Nearest Refseq:	NR_104178
Nearest Ensembl:	ENSG00000251143
Gene Name:	nuclear mitotic apparatus protein 1
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.550000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NUMA1 p2@NUMA1 p3@NUMA1 p4@NUMA1 p5@NUMA1 p6@NUMA1 p7@NUMA1 p8@NUMA1 p9@NUMA1 p10@NUMA1
Sample		p1@NUMA1	p2@NUMA1	p3@NUMA1	p4@NUMA1	p5@NUMA1	p6@NUMA1	p7@NUMA1	p8@NUMA1	p9@NUMA1	p10@NUMA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.92	45.00	0.00	0.39	0.00	0.00	1.56	2.73	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2.02	46.53	0.00	0.00	0.20	0.00	1.21	1.82	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	3.67	40.70	0.00	0.39	0.00	0.00	1.54	3.67	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.91	41.79	0.00	0.00	0.00	0.00	0.42	1.66	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1.35	47.92	0.22	0.00	0.00	0.00	0.67	3.15	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1.36	40.70	0.00	0.00	0.00	0.00	1.16	1.74	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	4.14	44.45	0.44	0.44	0.00	0.00	1.09	3.05	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.15	40.45	0.24	0.00	0.00	0.00	1.70	1.70	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.21	35.90	0.85	0.00	0.21	0.43	1.92	3.63	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	3.48	42.89	1.16	2.32	0.00	0.00	1.74	4.64	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.43	52.55	0.81	0.81	0.00	0.00	0.00	2.02	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.03	39.03	1.63	0.81	0.00	0.00	1.22	3.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.66	13.70	9.35	9.03	5.96	1.93	0.97	0.32	3.87	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.27	10.98	7.52	8.27	4.36	2.71	1.05	0.60	4.06	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.03	10.32	7.25	5.93	4.39	3.51	1.10	0.00	3.29	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.44	10.31	9.56	5.03	3.52	1.51	0.50	0.25	4.02	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.43	10.92	9.83	6.55	3.93	1.31	0.66	0.44	2.84	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.06	13.50	6.75	8.01	8.86	2.53	0.42	0.00	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.59	11.20	5.33	8.53	6.40	4.27	2.13	0.00	2.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	28.88	10.83	5.87	5.87	3.76	1.81	0.90	0.30	2.56	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	34.08	11.23	8.15	7.22	4.81	2.41	0.80	0.13	2.27	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.32	12.77	6.73	9.15	3.45	4.32	1.38	0.52	2.07	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	31.80	10.34	6.46	7.76	5.56	2.33	0.52	0.39	2.46	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.66	10.68	9.22	5.34	2.91	0.97	1.21	0.24	2.67	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.41	7.74	8.77	5.68	6.19	3.35	0.52	0.26	3.10	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	32.28	9.81	7.60	6.96	6.65	1.27	1.90	0.63	2.53	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.12	7.14	6.04	5.49	4.40	2.75	1.10	0.55	3.85	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	31.83	17.68	4.72	5.89	4.95	3.06	0.71	0.24	1.89	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.30	10.82	5.65	6.14	2.75	3.23	0.65	0.48	1.78	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.77	9.95	7.78	6.51	4.34	1.81	0.72	0.18	1.81	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	24.91	11.51	5.02	4.40	2.72	2.09	1.05	0.42	2.93	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.40	12.90	4.49	7.03	5.47	1.37	0.20	0.78	2.93	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.76	10.34	6.96	5.91	3.17	1.48	0.63	0.84	1.90	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.51	14.35	7.92	7.59	4.45	2.14	0.66	0.16	3.79	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.38	11.22	4.30	5.05	2.99	0.93	0.75	0.93	1.31	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.78	7.28	6.90	4.79	3.64	1.15	0.38	0.57	3.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.50	7.56	3.47	6.34	2.66	2.04	0.20	0.00	1.64	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	20.35	9.67	5.04	4.84	3.22	2.22	0.60	0.00	1.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.69	16.75	7.29	2.97	3.24	1.08	1.35	0.27	1.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	23.77	7.68	6.00	3.36	2.16	1.20	2.40	0.00	3.84	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.59	8.94	7.06	3.29	2.59	0.94	0.94	0.00	1.18	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.59	10.98	5.71	3.66	3.07	1.46	0.59	0.29	2.78	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	20.88	7.38	5.06	2.11	3.59	2.53	0.84	0.00	2.11	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	19.76	9.79	5.59	1.92	1.40	2.62	1.57	0.52	2.10	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.27	11.24	3.61	3.01	2.21	2.01	0.80	0.00	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.38	10.47	3.49	2.33	1.86	0.93	0.47	0.23	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.48	8.16	2.40	0.96	2.40	1.92	1.44	0.00	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.27	9.54	7.15	1.49	4.77	1.79	0.00	0.30	2.68	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.35	7.18	5.03	1.20	2.39	1.68	0.72	0.00	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.86	12.13	5.05	1.42	1.62	0.61	0.20	0.40	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.68	10.66	4.10	2.87	3.48	1.43	0.00	0.00	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.24	11.34	4.23	1.78	3.56	1.11	0.44	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	13.99	13.99	0.00	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	20.94	10.29	3.90	2.13	2.13	1.77	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.88	10.60	6.63	2.65	2.98	2.65	0.33	0.66	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	32.72	14.26	6.71	2.52	6.71	0.84	0.84	0.00	2.52	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.39	12.86	6.43	4.13	5.51	3.21	0.46	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.77	9.72	5.83	1.30	0.32	0.32	0.65	0.97	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.77	5.78	6.42	0.96	0.32	0.96	0.64	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	28.60	12.26	10.37	1.89	5.97	0.94	1.26	0.63	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	2.82	6.35	0.00	0.71	0.71	0.71	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	4.49	8.97	0.00	1.12	2.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	11.15	7.17	3.18	7.17	3.98	0.00	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	24.12	8.49	11.55	0.34	5.44	2.38	0.00	0.00	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.55	4.22	7.15	0.65	1.30	1.62	0.65	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.04	5.32	12.42	1.42	1.42	0.71	0.00	0.00	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	23.69	0.00	0.00	7.90	0.00	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	4.88	7.31	0.49	1.46	1.46	0.00	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	6.94	12.40	0.99	1.49	0.50	0.50	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	9.38	13.60	0.00	1.41	0.47	0.94	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.60	11.26	11.26	0.33	4.64	0.66	0.66	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.37	8.35	8.04	0.93	5.26	1.24	0.62	0.62	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.54	7.95	8.87	0.00	2.75	0.61	0.00	0.00	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	23.12	3.80	2.53	4.43	2.06	1.11	0.16	0.63	1.11	0.48
Adipocyte - breast, donor2	11327-117E4	17.65	4.97	9.47	2.73	0.96	1.60	0.00	0.16	0.48	0.64
Adipocyte - omental, donor1	11473-119C6	29.52	5.09	4.07	2.93	1.53	2.29	0.13	0.51	0.64	0.51
Adipocyte - omental, donor2	11474-119C7	14.20	6.73	2.24	2.24	1.49	0.75	0.00	1.49	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	9.38	3.68	3.68	4.69	0.33	2.01	0.00	0.67	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	6.38	3.19	0.00	1.91	1.91	1.28	0.64	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	3.30	0.00	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.84	4.06	7.68	0.90	0.00	0.00	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	15.29	5.56	4.52	2.43	0.70	0.87	0.00	0.52	0.70	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	31.29	5.87	16.04	2.35	0.78	1.96	0.00	0.39	0.98	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	20.08	7.98	8.75	1.03	0.26	1.29	0.26	0.51	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	23.70	7.53	15.05	2.79	1.12	0.56	0.00	0.84	2.79	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	7.64	14.11	3.53	0.59	0.59	0.00	1.18	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	21.15	4.67	30.56	3.46	0.48	1.61	0.24	0.72	1.05	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	25.50	3.87	16.46	2.26	0.65	0.97	0.32	0.65	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	26.66	3.20	10.66	6.93	0.53	0.53	0.00	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	13.91	5.01	24.48	3.34	1.11	0.56	0.00	0.56	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	15.39	5.82	19.96	4.57	0.00	0.42	0.83	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	18.84	4.27	15.82	1.76	1.51	1.00	0.00	0.50	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	18.33	4.25	19.31	4.58	0.65	0.65	0.00	1.64	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	7.61	3.65	16.44	1.22	0.00	0.61	0.00	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	26.74	5.75	0.00	1.33	0.00	0.88	0.22	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	15.78	3.23	0.00	0.72	0.00	2.51	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	13.18	3.59	0.00	1.20	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.51	34.72	9.71	0.00	0.90	0.18	2.52	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	15.06	8.37	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	26.71	17.87	12.53	0.41	0.21	0.41	1.64	0.62	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	38.33	5.49	18.77	3.78	8.01	2.40	0.57	0.11	3.78	2.06
Anulus Pulposus Cell, donor2	11463-119B5	17.39	3.43	5.63	2.45	3.67	3.18	0.00	0.00	1.96	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.67	2.25	5.84	0.90	0.45	0.90	0.45	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.06	5.21	6.95	1.30	2.60	0.43	0.00	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	2.14	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.12	3.59	3.59	1.79	1.20	0.90	0.00	0.00	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	5.06	2.53	3.79	0.00	2.53	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	1.98	1.98	0.66	0.66	1.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.37	3.25	3.25	0.97	1.62	0.65	0.32	0.32	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	3.40	0.97	1.46	1.94	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	1.19	4.75	0.00	1.78	0.59	0.00	0.00	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	20.34	4.52	4.14	4.14	1.13	1.51	0.00	0.00	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	3.63	1.45	0.73	1.45	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	2.51	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	22.57	3.13	6.26	1.15	1.48	0.49	0.00	0.00	0.99	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	2.73	1.36	0.00	0.00	0.00	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.34	1.81	3.17	0.60	1.06	0.90	0.45	0.15	0.75	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	5.89	5.36	2.14	0.00	1.61	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	18.52	4.16	3.97	1.51	1.13	1.32	0.19	0.00	1.13	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.71	3.21	4.54	1.87	1.34	1.07	0.00	0.00	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	2.93	2.93	2.93	1.95	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.23	2.16	3.65	1.00	0.66	1.16	0.33	0.33	1.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	8.41	2.40	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	0.00	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.81	4.29	4.63	1.03	0.86	1.37	0.00	0.17	1.54	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.81	4.85	2.91	2.43	0.00	0.49	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.15	4.93	6.07	1.52	1.14	2.28	0.76	0.38	2.66	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	1.21	4.85	0.00	1.21	2.42	0.00	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	6.27	3.42	1.71	0.00	1.14	0.57	0.00	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.52	4.49	4.06	1.07	1.50	2.14	0.21	0.00	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.61	4.65	3.10	1.29	0.26	0.00	0.52	0.26	1.29	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.95	4.22	7.04	1.88	0.47	0.00	0.00	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	2.89	3.54	1.29	1.61	0.64	0.00	0.00	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	2.14	2.14	1.43	0.71	0.00	0.71	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	3.51	1.75	0.00	1.75	2.92	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.18	4.22	3.31	1.20	2.41	0.60	0.00	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	5.94	1.19	0.00	4.75	1.19	0.00	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.45	3.56	2.54	0.51	2.54	2.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.67	3.06	5.35	1.27	2.80	0.76	0.00	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	2.54	6.35	1.27	0.00	0.00	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.40	3.45	2.59	2.16	0.86	1.29	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.78	4.23	7.20	1.27	2.54	1.27	0.42	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	3.77	3.19	0.29	2.03	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	3.78	3.78	0.00	1.89	2.83	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.97	4.07	4.92	1.02	1.02	0.68	0.00	0.17	1.02	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	2.32	2.32	0.00	2.32	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	4.23	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.65	3.00	3.22	1.93	1.29	1.29	0.43	0.00	1.50	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	1.80	3.01	0.60	1.20	0.00	0.00	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	2.92	2.19	0.73	0.73	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.77	3.68	4.37	0.92	1.38	0.69	0.23	0.23	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	2.55	0.00	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.22	2.03	3.05	0.51	0.51	1.02	1.02	0.00	0.51	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.72	3.10	3.10	0.83	1.86	1.03	1.45	0.00	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.89	3.37	3.67	1.22	2.45	0.92	0.61	0.00	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.03	2.87	1.43	0.48	1.91	2.87	0.48	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.73	4.43	3.99	0.67	1.77	0.00	0.22	0.22	2.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	3.05	4.58	0.00	0.00	1.53	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	3.88	2.77	0.55	1.11	1.11	0.00	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.18	5.83	3.71	0.53	0.79	1.59	0.00	0.00	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.99	5.09	2.54	1.82	0.73	1.82	0.36	0.00	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	33.28	48.88	8.72	2.95	6.26	1.23	2.21	0.25	0.74	0.61
Astrocyte - cerebellum, donor2	11580-120F5	26.19	32.69	7.53	2.23	4.79	0.86	1.03	0.51	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	35.66	11.96	7.97	4.19	5.87	1.47	0.63	0.84	1.89	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	13.59	44.27	5.93	3.14	1.74	0.35	2.79	0.70	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	12.62	60.50	8.57	1.78	1.62	0.49	1.94	0.65	0.00	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	8.95	44.45	2.39	1.04	1.64	0.30	1.79	1.49	0.60	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	16.17	37.73	8.14	0.11	0.34	0.46	2.29	0.23	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.03	39.84	7.89	0.13	0.38	0.50	2.88	0.25	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.45	43.24	6.94	0.34	0.34	0.46	2.05	0.23	0.11	0.00
Basophils, donor1	12241-129G9	25.37	11.51	29.03	1.31	1.83	4.45	0.00	0.26	0.78	0.26
Basophils, donor2	12242-129H1	42.93	19.12	23.81	1.08	4.33	2.89	0.00	2.16	3.25	0.00
Basophils, donor3	12243-129H2	20.43	8.23	23.81	0.73	2.50	0.29	0.15	0.88	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	16.60	12.50	4.74	0.00	2.80	0.43	3.23	0.22	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	14.17	1.37	0.00	2.29	0.00	2.29	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	0.00	7.17	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	25.11	2.51	0.00	1.26	1.26	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.57	18.51	1.25	0.42	0.83	0.21	2.29	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	7.37	3.22	0.00	1.61	0.46	2.76	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	10.98	8.82	0.72	0.18	3.24	0.72	1.98	0.00	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	8.35	74.92	0.93	0.00	0.00	0.00	6.18	0.21	0.72	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	36.10	41.69	2.33	0.23	0.70	0.47	6.52	0.00	1.16	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.54	30.38	0.96	2.56	6.08	1.28	1.28	0.64	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68	0.00	20.68	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.40	5.07	23.67	0.00	1.69	1.69	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	16.33	11.14	21.16	0.74	1.48	2.78	0.19	0.93	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	13.61	10.32	18.88	0.00	1.54	3.73	0.00	1.32	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	27.46	9.62	41.32	1.13	5.09	1.70	0.85	1.42	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.91	10.99	34.12	1.90	2.65	2.65	0.38	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.63	9.20	41.75	0.66	4.27	1.97	0.33	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	24.72	8.96	67.07	1.01	2.60	1.30	0.00	0.29	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	16.90	5.73	41.34	0.30	1.51	1.21	0.30	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	23.69	8.77	51.88	0.00	2.13	0.71	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	14.56	4.85	40.51	0.33	1.17	1.00	0.17	0.17	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	9.38	7.18	25.67	0.83	1.66	0.00	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.40	6.45	22.81	0.00	0.74	0.25	0.00	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.01	4.11	18.01	0.00	0.98	0.00	0.00	0.39	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	9.08	5.16	17.27	0.18	2.14	0.36	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.31	5.44	14.15	0.44	1.52	0.22	0.00	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	10.54	5.38	23.65	0.00	1.87	0.23	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	9.50	17.42	0.53	1.06	0.00	0.53	0.53	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	5.55	18.86	1.11	2.22	0.00	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.73	9.22	59.80	0.15	1.78	0.74	0.15	0.59	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	12.37	5.99	42.50	0.20	0.60	0.20	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	13.74	8.33	36.64	0.62	0.83	0.21	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.75	7.55	44.61	0.92	0.92	0.00	0.00	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	13.57	4.07	30.09	0.00	0.90	0.45	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.60	6.11	26.19	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	11.30	3.77	27.17	0.81	2.15	0.27	0.00	0.54	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.97	7.68	21.81	0.17	1.40	0.17	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.94	5.89	16.41	1.26	0.42	0.42	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.98	3.86	31.05	0.00	0.18	0.18	0.00	0.73	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	4.23	20.08	0.35	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	4.83	26.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.10	3.66	19.53	0.52	1.92	0.35	0.17	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	5.20	18.96	0.74	1.49	0.74	0.37	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	8.41	8.84	19.40	0.22	0.86	0.86	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.96	5.32	23.75	0.41	2.87	0.00	0.00	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.97	4.64	17.15	0.93	0.46	0.00	0.00	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.57	2.78	15.54	0.23	0.46	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	10.03	7.63	16.35	0.22	0.65	1.09	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	16.40	4.85	17.56	0.23	1.85	0.92	0.23	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.48	4.12	17.98	0.43	1.08	0.22	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	22.27	5.92	48.27	0.62	3.11	0.78	0.00	0.00	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	26.37	5.59	31.79	0.52	3.14	1.40	0.17	0.17	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	22.07	5.35	58.19	1.56	3.57	0.67	0.22	0.22	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	17.35	5.10	12.50	0.26	1.79	0.77	0.00	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	3.73	14.93	1.10	1.32	0.66	0.00	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	12.42	8.00	18.53	0.00	0.42	0.42	0.00	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	8.13	0.00	0.00	0.00	14.23	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	10.17	0.68	2.03	2.03	8.81	1.36	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	11.39	2.07	1.04	2.07	5.18	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.17	10.66	3.20	2.67	4.26	6.93	0.53	0.00	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	64.33	8.04	1.07	2.68	3.22	11.79	1.07	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	40.71	12.63	0.00	2.81	4.21	11.93	0.70	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	10.20	0.00	1.57	3.14	12.55	0.78	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	48.78	3.95	0.00	5.27	1.32	13.18	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	65.75	22.19	0.82	3.29	2.47	19.73	1.64	3.29	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	53.68	18.86	1.45	3.63	2.90	12.33	0.73	3.63	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	72.19	14.64	0.50	3.03	2.02	13.63	1.01	1.51	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	8.89	168.49	2.02	0.00	0.00	0.40	7.68	8.89	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	8.39	108.66	2.00	0.00	0.00	0.00	5.99	6.39	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	58.23	16.06	1.00	6.02	11.04	3.01	0.00	1.00	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	23.03	19.66	1.12	3.93	5.62	4.49	0.56	0.56	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	23.30	30.81	4.13	0.38	1.88	1.88	1.50	0.00	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.03	34.95	2.48	1.80	2.03	1.80	1.35	0.00	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	63.56	27.85	0.00	8.57	5.71	21.78	2.86	1.43	3.57	3.57
CD4+ T Cells, donor2	11306-117C1	45.31	26.94	0.61	7.96	7.35	15.92	3.06	1.84	7.35	3.67
CD4+ T Cells, donor3	11382-118B5	58.86	34.16	0.00	5.79	7.01	19.82	1.83	3.35	2.74	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	39.31	16.59	0.00	3.57	2.30	13.53	3.83	1.28	2.81	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.74	21.11	0.00	3.14	3.82	9.88	3.14	0.67	3.37	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	59.50	15.52	0.00	3.16	1.15	13.51	2.87	1.72	2.30	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	51.20	10.43	0.00	6.64	6.16	12.33	0.47	1.90	1.42	4.27
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	55.48	14.75	0.00	6.32	5.62	19.67	1.40	4.92	3.51	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	16.48	0.00	9.89	6.59	16.48	3.30	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.75	24.71	1.16	2.60	2.89	9.10	3.61	0.58	1.16	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.33	27.28	0.34	1.86	1.86	6.95	4.07	0.00	0.68	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	41.91	26.92	0.32	1.93	1.61	7.74	5.64	0.81	1.77	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	35.86	17.48	0.00	4.03	5.38	13.00	1.79	1.34	1.79	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	30.05	10.83	0.00	4.54	4.19	12.58	0.35	0.35	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	61.60	17.60	0.44	7.48	4.84	18.92	3.08	3.08	3.96	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	43.01	38.79	0.84	4.64	5.48	10.54	1.69	0.00	2.53	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.36	30.13	0.21	2.49	2.29	3.95	4.57	0.00	1.66	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.40	30.07	0.00	1.34	3.01	3.68	2.00	1.00	3.01	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	71.52	14.41	0.00	10.88	6.80	25.56	2.72	2.18	6.53	5.17
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.92	19.83	0.00	12.86	6.97	24.12	2.14	5.36	5.90	5.36
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	23.31	0.00	8.97	3.59	17.93	0.00	1.79	5.38	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.97	39.31	0.19	2.23	2.97	8.16	5.56	1.30	1.48	0.74
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.51	34.88	0.87	2.17	0.65	4.77	5.20	0.43	0.65	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	35.94	32.15	0.84	1.26	0.84	5.04	5.67	0.84	1.05	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	33.37	11.12	0.00	1.52	3.54	13.15	2.02	1.52	5.06	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	38.99	14.73	0.00	4.77	3.03	13.86	0.43	0.43	1.73	3.47
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	61.89	21.79	0.44	4.79	4.36	23.10	0.87	0.44	6.54	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.34	8.91	3.96	6.93	5.94	15.34	2.97	0.99	2.97	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	46.16	8.31	1.85	1.85	4.62	12.00	1.85	2.77	3.69	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	8.37	2.79	2.79	8.37	11.17	1.40	2.79	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.68	14.68	6.65	6.09	3.60	23.26	2.49	1.94	2.77	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	79.75	14.72	5.64	4.42	4.91	28.47	2.70	1.72	5.40	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	50.82	16.94	9.24	7.70	4.62	27.72	0.00	0.00	4.62	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	76.64	15.40	5.37	2.86	3.94	11.82	0.72	1.43	1.43	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	52.63	8.31	1.38	4.15	6.92	16.62	0.00	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	78.25	22.26	2.29	2.95	5.89	18.99	0.33	2.62	3.93	0.65
CD8+ T Cells, donor2	11307-117C2	36.42	23.65	0.38	0.75	3.00	10.51	1.50	2.25	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	51.76	22.72	0.50	3.28	4.80	16.92	2.27	3.53	2.02	3.03
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.61	19.73	15.83	0.23	0.23	0.00	0.92	0.23	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.48	21.33	16.06	0.00	0.00	0.00	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.64	22.71	22.16	0.27	0.00	0.00	0.55	0.82	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.80	30.02	24.92	0.00	0.00	0.00	0.30	1.80	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	17.04	17.28	0.00	0.00	0.00	1.20	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.41	21.15	17.74	0.00	0.00	0.00	0.91	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.52	23.90	16.73	0.00	0.22	0.00	0.87	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.11	27.90	16.06	0.00	0.00	0.26	0.79	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.17	30.96	15.01	0.00	0.23	0.00	0.00	0.23	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.72	35.62	24.15	0.00	0.00	0.00	0.60	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.78	27.02	24.98	0.00	0.00	0.29	0.87	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.87	37.83	21.31	0.00	0.00	0.00	0.80	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1.75	30.64	13.13	0.00	0.00	0.44	0.44	0.44	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.19	34.61	13.21	0.00	0.00	0.46	0.91	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	28.34	11.19	0.00	0.00	0.00	2.24	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.44	20.53	16.57	0.00	0.00	0.00	1.08	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.01	23.31	17.84	0.00	0.00	0.00	0.58	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.06	16.97	14.85	0.00	0.24	0.00	1.18	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.22	28.20	12.99	0.00	0.00	0.00	0.95	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.38	29.83	14.15	0.00	0.00	0.00	0.00	1.23	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.24	29.49	12.82	0.64	0.00	0.32	0.64	1.92	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.21	28.68	17.98	0.00	0.00	0.00	0.76	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2.36	28.77	20.10	0.00	0.00	0.00	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.03	19.67	19.67	0.00	0.00	0.00	1.51	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.03	20.07	28.10	0.00	0.80	0.00	0.00	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	41.27	29.38	0.70	0.00	0.00	0.70	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	8.01	32.06	22.04	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	0.00	1.83	3.66	0.00	0.00	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	19.27	7.41	1.98	1.98	0.49	0.00	0.00	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	13.05	6.84	1.26	0.32	0.53	0.42	0.53	0.00	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	12.48	26.69	7.63	2.08	1.39	1.73	0.35	0.35	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	23.45	4.26	7.11	5.33	0.71	2.13	0.00	0.71	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	20.03	3.53	10.58	3.53	1.14	1.71	0.46	0.46	1.14	0.34
Chondrocyte - re diff, donor2	11339-117F7	23.28	8.95	23.28	3.58	0.90	2.69	1.79	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	20.22	8.90	14.96	2.43	9.30	4.45	0.40	1.21	2.02	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	35.12	42.00	17.33	1.61	5.85	1.15	2.75	0.57	0.57	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	17.74	19.88	9.62	1.71	2.35	0.64	1.92	0.64	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	29.29	21.24	9.47	1.50	2.65	0.80	2.04	0.35	0.53	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	71.89	24.94	12.65	8.80	5.87	4.77	5.23	8.44	4.40	3.67
Corneal Epithelial Cells, donor1	11526-119I5	8.34	27.45	3.73	0.22	3.51	0.66	5.71	0.22	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	7.96	35.27	3.41	0.00	3.41	0.00	5.69	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	7.16	24.80	2.81	0.00	1.28	0.26	6.39	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.69	10.07	18.49	0.17	1.32	0.66	0.66	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.56	11.04	15.77	0.00	1.58	1.26	0.32	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	10.35	3.45	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.42	8.21	19.11	0.54	2.59	0.32	0.43	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	80.29	12.30	4.10	24.60	7.17	4.78	0.00	1.37	4.10	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	40.48	9.79	1.96	16.32	4.57	2.61	0.65	0.65	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	46.46	15.49	0.48	29.52	4.84	3.39	0.00	0.97	2.90	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	14.18	22.85	24.18	1.33	0.33	0.33	1.00	0.17	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	7.63	7.04	5.87	0.00	0.59	1.17	0.00	1.17	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.88	21.21	16.12	1.13	0.00	0.00	0.57	0.00	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	14.15	1.57	0.79	0.79	1.18	0.00	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.93	6.69	6.40	0.58	0.87	1.45	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	12.23	16.00	15.76	0.24	0.24	0.24	1.18	0.47	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	9.82	18.23	16.48	0.35	0.88	0.70	0.88	0.70	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.38	9.53	4.21	1.11	3.10	0.66	0.66	1.11	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.43	7.30	3.96	0.61	3.35	1.52	0.91	1.83	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	26.78	11.84	7.61	2.54	3.10	1.69	0.56	2.82	1.13	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	24.07	13.67	11.59	0.30	2.67	2.38	1.78	0.89	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	11.98	7.29	5.21	0.52	0.00	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.60	10.35	2.69	2.55	2.69	1.42	0.85	1.42	0.85	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	10.80	19.21	22.41	0.80	0.80	0.80	1.20	0.40	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	7.34	10.48	0.00	0.52	1.05	1.05	0.00	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.71	45.60	11.55	1.74	2.24	0.99	1.24	0.99	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.47	24.99	5.21	0.43	1.52	0.43	1.09	0.65	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.75	25.77	2.81	0.61	0.49	0.49	0.73	0.49	0.37	0.12
Endothelial Cells - Vein, donor1	11267-116G7	6.83	19.34	4.55	1.14	0.00	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.76	30.73	8.38	1.40	0.70	0.00	1.40	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	10.83	16.64	10.99	0.63	1.26	0.79	0.79	0.63	0.47	0.31
Eosinophils, donor1	12244-129H3	45.74	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	14.85	3.30	3.30	3.30	1.65	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	21.40	21.40	7.13	3.57	3.57	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	16.61	0.98	0.00	1.22	1.22	3.91	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	12.48	2.08	0.00	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.42	6.16	6.16	0.41	0.82	1.64	0.41	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.27	0.44	0.77	0.00	0.33	0.22	0.33	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.74	5.63	3.03	0.54	0.11	0.11	0.43	0.11	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.16	12.01	5.58	1.09	0.97	0.73	0.73	0.12	0.85	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	36.44	9.55	11.05	1.64	3.00	2.73	0.41	0.68	0.96	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.71	3.06	4.85	0.63	0.84	0.74	0.00	0.63	0.74	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	36.36	37.15	13.44	3.69	3.95	1.84	0.53	0.26	1.58	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	16.28	20.26	4.65	0.33	0.66	1.00	1.33	0.33	1.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	14.06	5.44	3.18	4.08	1.36	0.45	0.91	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	6.06	7.58	10.61	0.76	0.76	0.76	0.00	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	10.88	4.57	6.78	0.32	1.42	0.79	0.00	0.00	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	28.19	9.09	3.64	2.73	0.61	1.52	0.61	0.30	2.12	0.61
Fibroblast - Cardiac, donor5	11456-119A7	12.94	9.39	7.99	0.51	1.02	0.51	0.25	0.25	0.89	0.25
Fibroblast - Cardiac, donor6	11460-119B2	13.34	18.04	3.18	1.36	0.30	0.76	0.15	0.76	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.64	13.00	4.82	6.16	6.16	1.61	0.67	0.27	1.74	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.97	6.04	1.29	3.88	1.73	0.86	0.43	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	16.11	2.93	0.00	4.39	0.00	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	29.29	38.06	13.61	2.77	3.92	1.15	0.46	0.69	1.15	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	63.43	6.78	4.58	29.85	1.70	1.87	0.00	0.51	2.88	1.53
Fibroblast - Dermal, donor1	11269-116G9	10.33	5.17	7.28	0.00	0.70	1.17	0.00	0.23	1.17	0.70
Fibroblast - Dermal, donor2	11346-117G5	10.38	19.81	3.77	0.00	0.94	0.00	0.47	0.00	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	8.95	6.89	5.44	0.12	0.36	0.12	0.24	0.12	0.97	0.00
Fibroblast - Dermal, donor4	11450-119A1	9.61	29.73	1.47	0.57	1.36	0.11	0.45	0.11	0.79	0.45
Fibroblast - Dermal, donor5	11454-119A5	7.15	34.54	2.62	0.52	1.74	0.17	0.70	0.17	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	8.93	39.14	2.60	0.49	0.65	0.32	0.65	0.49	0.49	0.00
Fibroblast - Gingival, donor1	11237-116D4	22.07	10.62	27.07	0.42	4.37	0.83	0.21	0.83	2.50	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	24.63	8.65	18.08	1.31	3.67	1.31	0.00	0.52	1.31	0.52
Fibroblast - Gingival, donor2	11318-117D4	14.23	26.09	9.88	0.92	2.90	0.13	1.19	0.66	0.40	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.82	8.80	20.59	0.97	4.25	0.97	0.10	0.29	1.64	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	11.43	11.43	4.16	0.00	2.08	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.97	4.58	12.69	0.35	0.53	0.53	0.00	0.00	2.47	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.76	28.22	10.91	1.40	2.18	1.71	1.09	0.00	1.09	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.17	24.07	16.23	0.54	1.89	0.81	0.54	0.27	2.16	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	3.18	3.18	0.71	0.35	0.71	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	23.55	17.26	8.77	0.58	1.90	2.05	0.15	0.00	1.17	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.59	24.95	14.86	0.82	2.45	2.18	0.27	0.41	2.18	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	7.57	26.77	6.25	0.55	1.54	0.77	0.33	0.00	0.33	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	45.64	3.37	9.24	6.75	2.93	2.49	0.00	0.15	4.40	0.59
Fibroblast - Lung, donor1	11270-116H1	13.59	20.39	6.80	0.00	0.00	0.00	0.00	0.00	2.72	1.36
Fibroblast - Lung, donor2	11347-117G6	40.29	26.86	0.00	1.49	2.98	1.49	0.00	1.49	8.95	0.00
Fibroblast - Lung, donor3	11419-118F6	18.57	21.10	3.59	0.00	1.69	0.42	0.21	0.00	1.27	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	37.49	22.49	14.16	2.50	3.33	1.67	0.00	0.83	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	4.20	2.80	1.40	1.40	2.80	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	9.52	4.20	3.08	0.00	0.28	1.40	0.00	0.00	1.12	0.00
Fibroblast - Mammary, donor1	11540-120B1	26.39	31.67	6.90	0.00	1.22	2.03	1.22	0.41	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	7.99	7.99	0.00	0.00	3.99	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	0.00	0.00	0.00	0.00	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	20.37	37.44	12.03	0.78	1.16	0.19	0.39	0.78	1.36	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.99	49.45	6.67	0.61	1.82	0.30	0.30	0.61	1.21	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	11.93	17.75	17.75	0.00	0.92	0.92	1.22	0.31	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.21	12.59	8.78	0.00	0.00	1.14	0.00	0.00	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.31	8.37	6.48	1.35	0.54	0.54	0.00	0.00	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.83	5.33	10.32	2.09	0.46	1.51	0.12	0.00	1.62	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.28	14.37	2.54	0.22	0.33	0.00	0.99	0.22	0.55	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.77	33.53	14.43	1.22	1.02	0.61	0.41	0.00	1.22	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	30.74	9.35	0.00	2.00	1.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	8.30	4.35	0.40	1.98	0.79	0.40	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	38.10	74.02	23.81	3.77	6.95	3.77	0.99	0.99	2.38	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.06	5.15	7.46	2.84	2.84	1.42	0.36	0.18	3.20	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.03	6.90	8.28	0.59	0.99	1.38	0.20	0.20	2.96	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	34.60	52.05	18.35	1.81	4.21	2.71	0.60	0.00	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.63	9.39	7.02	2.27	4.10	2.05	0.11	0.43	1.73	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	65.80	17.72	27.84	3.04	9.36	5.57	0.25	0.51	2.02	0.51
Fibroblast - skin normal, donor1	11553-120C5	30.68	4.59	10.34	1.80	3.28	1.80	0.66	0.82	1.31	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	45.11	56.34	28.07	1.60	2.61	1.80	1.40	0.60	1.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	21.00	13.86	11.65	2.61	2.41	1.81	0.70	0.30	1.21	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	73.14	51.08	38.08	3.93	7.86	4.84	0.30	1.51	2.72	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.49	5.72	12.59	2.07	3.31	1.74	0.08	0.17	2.65	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	46.67	9.23	6.15	17.27	3.93	6.33	0.34	0.17	4.44	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.40	33.83	27.59	1.97	7.88	3.94	0.99	0.66	1.64	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.32	21.20	11.82	0.96	3.09	1.17	1.07	0.00	0.96	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	20.92	24.63	13.83	1.35	2.87	1.86	1.52	0.00	1.52	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.09	3.29	8.47	1.10	2.82	0.78	0.63	0.47	1.10	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	66.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	13.94	7.84	0.00	3.49	0.87	6.97	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.79	12.83	4.51	0.17	0.52	0.35	4.33	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	9.63	13.27	5.20	0.26	1.04	0.00	2.08	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	12.01	17.63	3.83	0.26	0.77	0.00	3.07	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	28.33	0.00	0.77	0.00	0.00	3.06	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	7.02	33.82	0.00	1.28	0.00	0.00	1.91	0.64	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	5.99	46.21	0.00	1.14	0.29	0.29	3.71	1.71	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.72	56.81	0.00	16.55	0.00	1.10	4.69	1.38	3.03	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.44	41.10	0.46	8.22	0.23	0.23	2.28	0.91	1.14	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	7.33	35.66	0.00	4.95	0.99	0.20	2.18	0.79	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.69	45.20	0.00	15.07	1.59	1.06	2.91	1.06	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	15.00	51.21	0.00	6.20	0.98	0.98	2.28	0.98	2.28	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	5.75	34.49	0.00	0.88	0.00	0.00	2.21	0.00	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.34	40.84	0.00	2.83	0.85	0.42	2.54	0.14	0.99	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.96	37.19	0.86	6.53	1.11	0.25	2.34	0.99	1.23	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	27.94	0.54	2.15	0.54	0.00	0.81	0.00	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	6.07	24.41	3.47	2.23	0.50	0.12	1.12	0.37	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	4.71	32.39	3.60	1.66	0.55	0.14	1.25	0.28	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	4.27	22.77	3.86	0.61	0.20	0.00	1.22	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.29	28.29	5.70	4.34	0.46	0.23	0.68	0.68	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.46	26.91	2.37	2.37	0.37	0.12	1.37	0.62	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.99	22.51	3.93	0.44	0.66	0.00	1.75	0.87	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.48	24.52	1.18	3.84	1.77	0.00	1.48	0.89	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.40	34.18	1.43	5.88	0.95	0.64	0.64	0.64	0.64	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	7.37	23.24	3.13	3.13	0.67	0.00	2.01	1.12	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.96	34.48	1.21	6.05	1.61	0.81	0.40	0.81	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.12	35.46	2.04	7.29	0.68	0.34	1.02	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.93	37.51	6.03	3.99	0.89	0.62	2.04	1.42	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.76	36.73	6.04	10.72	3.43	0.83	1.04	1.46	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.04	40.99	5.64	14.52	3.76	0.51	0.85	1.71	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.04	30.32	1.66	8.96	2.10	1.00	0.77	0.55	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.13	35.19	4.41	4.58	1.66	0.58	1.66	1.33	0.50	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.87	36.55	4.08	5.72	1.63	1.23	1.02	1.02	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.26	26.20	3.09	7.63	3.09	0.62	0.62	0.62	0.83	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.29	29.52	2.19	11.64	3.80	0.58	0.69	1.61	1.15	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.18	24.35	2.67	5.00	1.83	0.00	1.33	0.33	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.03	17.41	3.53	5.51	3.09	0.44	1.76	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.25	23.00	2.83	11.44	2.09	0.74	0.98	1.48	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	21.40	28.69	3.40	5.67	2.11	0.16	1.13	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.94	17.32	1.60	10.26	5.77	1.60	0.00	1.60	1.28	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.86	24.45	2.27	7.01	2.46	0.19	0.76	1.42	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	21.83	4.59	3.95	2.21	0.16	0.47	0.95	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.28	21.29	3.95	2.13	2.43	1.22	1.22	0.91	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.34	26.24	3.14	8.47	1.67	0.84	0.84	0.52	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.98	16.91	2.20	4.17	3.51	0.44	0.66	0.88	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	18.80	18.80	4.77	7.01	1.96	0.28	1.12	2.24	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.20	18.15	3.98	2.96	1.94	0.83	0.83	0.74	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.31	17.38	6.15	2.41	0.80	0.80	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.77	22.80	3.52	1.53	2.14	0.61	0.77	0.77	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.12	20.21	2.59	2.59	2.20	0.52	0.39	0.52	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.55	11.66	4.34	2.44	2.98	0.27	0.00	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	28.94	12.54	2.77	4.42	2.95	2.03	1.29	0.18	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.34	12.94	3.07	6.14	4.61	1.54	0.22	0.44	2.19	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	6.94	1.98	5.95	6.94	2.98	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.74	17.94	1.98	3.17	4.22	1.06	0.79	0.66	0.66	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.60	12.91	4.24	3.23	5.65	0.40	0.40	0.00	1.21	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	41.43	10.93	3.56	6.61	10.93	0.76	0.25	1.52	3.30	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.16	55.94	0.00	1.99	0.40	0.40	2.99	0.20	1.39	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	3.24	45.76	0.00	2.77	0.77	0.00	3.39	0.31	1.69	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.16	59.94	0.20	5.93	0.00	0.61	3.89	0.41	2.25	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	4.07	36.93	0.31	1.88	0.00	0.00	2.19	0.63	2.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	3.39	31.93	0.00	1.70	0.00	0.28	1.13	0.00	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.61	48.43	0.46	5.53	0.00	0.00	6.00	0.92	6.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	42.07	2.47	9.90	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.58	39.84	0.39	5.42	0.00	0.39	2.32	0.77	4.25	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	33.69	0.00	1.60	0.00	0.00	0.00	1.60	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	39.99	0.00	0.00	0.00	0.00	1.74	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.51	32.22	0.65	0.98	0.65	0.00	2.28	0.65	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.47	40.36	0.00	6.59	0.00	0.82	1.65	2.06	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	49.98	0.00	3.33	0.00	3.33	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	7.83	34.96	0.28	2.52	1.40	0.00	1.12	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	6.21	31.70	0.00	1.63	0.00	0.00	0.65	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	7.55	50.33	0.84	3.36	0.00	0.84	1.68	0.84	3.36	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.09	38.17	1.27	3.50	0.95	0.00	1.27	0.95	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.45	25.47	0.68	2.38	1.36	0.34	2.72	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	29.23	2.09	4.18	0.00	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	11.45	42.95	0.00	5.15	0.00	0.00	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.47	29.89	0.89	2.37	0.30	0.00	0.00	0.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	22.02	0.00	5.08	0.00	0.00	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	16.57	33.55	1.66	5.38	0.41	0.83	1.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	16.11	36.13	1.15	5.06	0.69	0.23	0.92	0.46	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	26.34	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	29.98	1.15	5.77	0.77	0.38	0.77	0.00	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.73	31.95	0.65	3.59	0.98	0.33	1.30	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	16.72	0.67	2.68	0.67	0.00	2.01	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.88	31.98	0.39	2.70	0.39	0.77	0.77	0.77	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.38	38.00	0.68	3.42	0.34	0.34	0.34	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	32.30	0.00	4.97	4.97	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	20.29	40.11	0.94	2.36	1.42	0.00	1.42	2.36	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.71	27.16	1.21	1.81	0.00	0.00	3.02	1.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	32.05	1.53	9.16	1.02	0.51	0.51	0.51	2.03	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.96	26.32	1.20	5.98	0.80	0.40	0.80	0.00	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	19.24	27.63	0.00	6.91	1.48	0.99	0.99	0.99	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	40.13	1.18	7.08	4.72	1.18	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	29.76	0.00	7.00	0.58	0.00	0.00	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.68	28.97	0.00	6.14	3.51	0.44	1.32	0.44	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.11	31.36	0.00	2.54	0.00	0.00	0.85	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	21.49	31.04	1.79	2.39	0.60	0.00	1.79	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.95	23.29	0.97	4.37	0.97	0.00	1.46	0.97	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	4.57	9.13	0.00	3.42	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.36	4.16	12.06	0.83	3.74	2.08	0.00	0.42	1.66	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	13.49	12.37	1.12	4.50	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.47	3.49	4.76	2.54	1.90	2.22	0.00	0.00	3.17	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.37	2.92	3.76	1.25	1.67	0.42	0.00	0.00	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.05	20.31	5.45	0.46	0.23	0.35	1.28	0.46	0.35	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	5.06	21.94	4.56	0.68	0.34	0.00	1.69	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.23	22.07	4.10	0.91	0.00	0.00	1.37	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.67	22.95	4.26	0.33	0.00	0.22	1.20	0.33	0.22	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.37	24.50	3.22	0.86	0.00	0.21	2.36	0.21	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.67	19.59	6.46	0.00	0.00	0.43	1.08	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4.61	18.56	3.24	0.50	0.12	0.12	1.25	0.25	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	5.32	18.87	3.26	0.69	0.00	0.00	1.54	0.86	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.49	17.30	4.49	0.00	0.00	0.32	1.92	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	18.47	7.83	0.00	2.80	0.56	0.56	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	15.15	16.01	5.19	1.30	1.30	0.00	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	2.64	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.22	13.76	3.17	1.41	2.12	2.12	1.06	0.35	1.76	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	28.33	7.99	2.18	4.36	0.73	4.36	1.45	0.73	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	6.82	13.81	0.52	0.17	0.17	0.35	0.35	0.17	0.00	0.17
Hepatocyte, donor1	11523-119I2	21.79	12.11	1.21	1.21	3.63	2.42	1.21	3.63	1.21	1.21
Hepatocyte, donor2	11603-120I1	19.39	5.39	2.15	0.00	2.15	3.23	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	16.57	4.91	1.84	1.84	3.68	2.45	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	22.19	83.54	0.00	1.96	0.00	1.31	3.26	0.00	4.57	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.58	59.25	5.77	1.05	1.22	0.17	7.52	2.97	3.67	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	16.74	11.11	4.53	0.27	2.61	0.41	0.69	0.00	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	73.23	0.00	0.00	0.00	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	40.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	88.60	0.00	0.00	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	85.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	47.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	82.01	2.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	73.13	0.00	0.00	0.00	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	94.21	0.00	0.00	0.00	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	60.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	47.20	0.00	0.00	0.00	0.00	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	93.97	0.00	0.00	0.00	0.00	1.32	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	63.19	0.00	0.00	0.00	0.00	2.22	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	57.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.63	67.40	0.00	0.00	0.00	0.00	1.26	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	68.05	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	81.40	0.65	0.00	0.00	0.00	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	111.08	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	47.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	96.16	0.00	0.00	0.00	0.00	2.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	89.42	0.42	0.00	0.00	0.00	2.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	71.86	0.00	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	81.17	0.00	0.80	0.00	0.00	3.21	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	60.94	0.00	0.00	0.00	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	75.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	49.09	1.42	0.00	0.00	0.00	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	57.14	0.00	0.00	0.00	0.00	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	117.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	81.79	2.15	0.00	0.00	0.00	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	83.85	0.00	0.00	0.00	0.00	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	90.55	0.64	0.00	0.00	0.00	1.91	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	91.13	0.00	0.00	0.00	0.00	1.82	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	79.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	99.97	0.71	0.00	0.00	0.00	1.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	126.10	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	2.47	68.21	0.31	0.00	0.00	0.00	1.23	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	115.90	3.51	0.00	0.00	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	81.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	88.31	0.70	0.00	0.00	0.00	2.78	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	75.25	0.00	0.00	0.00	0.00	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	87.53	0.00	0.00	0.00	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	47.96	0.87	0.00	0.00	0.00	5.23	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	62.99	0.00	0.00	0.00	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	73.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	46.94	0.00	0.00	0.00	0.00	3.20	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	81.74	0.00	0.00	0.00	0.00	2.77	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	76.94	0.00	0.00	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1.84	68.11	0.92	0.00	0.00	0.00	1.84	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	66.56	0.00	0.00	0.00	0.00	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	68.30	0.00	0.00	0.00	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	34.89	0.00	0.00	0.00	0.00	0.00	1.06	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.81	12.73	5.55	0.24	3.10	0.57	5.06	0.00	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	6.44	6.44	2.34	0.00	1.76	0.00	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	4.54	22.34	0.28	0.00	0.47	0.19	3.50	0.00	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	28.38	26.68	3.63	1.14	9.65	1.48	5.68	0.34	2.50	0.11
Keratocytes, donor1	11527-119I6	26.82	26.82	27.51	6.53	4.13	1.03	0.69	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	11.72	23.44	5.86	4.69	0.00	1.17	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	16.80	4.74	8.50	9.29	2.77	1.38	0.00	0.00	1.19	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	35.17	0.00	0.00	2.20	2.20	4.40	2.20	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	19.42	2.16	0.00	1.08	0.00	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.03	16.61	14.53	2.42	5.77	1.61	1.27	0.81	1.38	1.15
Lens Epithelial Cells, donor3	11690-122I7	17.86	6.26	3.23	0.61	2.42	0.61	0.61	0.50	0.91	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	22.89	11.15	12.21	1.30	2.73	1.66	0.47	0.36	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.56	9.77	6.42	1.12	0.84	0.28	0.56	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.98	11.49	7.71	0.79	3.62	0.63	1.10	0.47	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.68	6.99	6.45	1.08	0.54	1.08	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.33	11.03	5.67	0.63	1.58	0.95	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.15	8.30	5.18	0.65	2.05	1.08	0.97	0.86	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.95	6.98	5.75	0.41	0.41	0.00	0.00	1.23	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.41	9.10	6.83	0.25	2.02	1.26	1.01	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.75	7.18	7.04	0.70	2.53	0.99	0.56	0.42	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	10.28	8.31	6.33	0.79	1.19	0.40	0.40	0.40	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.47	8.53	5.04	0.00	1.36	0.97	0.39	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.44	7.96	5.37	1.48	2.41	1.11	0.93	1.30	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.94	5.23	8.71	0.70	1.39	0.70	0.35	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.98	7.39	5.49	0.48	1.67	0.48	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.86	10.16	5.08	0.41	2.20	1.37	0.69	0.69	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	7.70	6.47	3.70	0.62	1.54	1.23	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	5.30	3.12	0.31	0.94	0.00	0.62	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.78	10.98	9.52	0.37	2.01	0.73	0.37	1.10	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	8.56	6.58	0.66	1.32	1.32	0.33	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.30	9.37	2.93	1.17	1.76	0.29	0.29	0.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.41	5.73	4.98	1.24	3.49	1.24	0.25	0.75	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.76	5.82	2.42	0.48	2.91	0.00	2.42	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.96	8.62	4.04	0.27	1.62	0.27	0.54	1.08	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.20	9.39	5.90	0.91	2.88	1.67	0.61	0.76	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	4.67	3.11	0.52	0.52	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	11.31	7.96	5.03	0.21	1.05	0.42	0.21	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.50	9.77	4.81	0.45	2.71	0.90	0.60	0.90	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	4.82	4.13	1.38	0.00	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.91	6.96	3.20	0.75	0.94	0.38	0.75	0.19	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.12	9.33	4.35	0.85	2.01	0.64	1.17	0.95	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.54	7.27	3.39	2.42	1.45	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.25	5.29	2.98	0.00	0.99	0.66	0.66	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	16.23	10.41	5.33	1.24	2.23	0.62	0.99	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.10	8.14	7.03	1.48	1.11	0.74	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	6.42	3.46	0.25	0.74	0.99	0.25	0.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.30	7.84	5.22	0.69	3.02	0.55	1.10	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.68	8.36	6.43	0.32	1.93	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.83	9.74	2.13	0.00	0.91	0.61	0.91	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.92	10.22	7.28	1.40	2.66	0.56	0.56	0.42	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.38	6.40	5.69	1.07	0.36	0.00	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	7.76	4.36	0.48	0.00	0.00	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.52	10.27	6.07	0.93	1.40	0.62	0.62	0.62	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	7.52	2.86	1.79	1.79	0.00	0.72	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.15	7.19	5.23	0.33	1.31	0.33	0.65	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	10.12	6.12	0.71	1.65	0.94	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.86	12.62	10.52	1.24	1.98	1.36	0.74	1.36	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.96	8.71	3.84	0.51	1.02	0.51	0.77	1.02	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.22	9.55	2.98	0.60	0.90	1.49	1.19	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	56.65	38.52	0.00	0.00	9.06	0.00	6.80	0.00	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.82	37.59	0.00	1.53	6.14	3.07	6.90	2.30	7.67	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	27.46	20.04	0.00	0.74	5.20	1.48	2.23	1.48	3.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	57.12	37.24	0.42	2.12	11.85	1.27	5.50	1.27	9.31	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	32.35	30.95	0.00	1.41	6.33	1.41	9.14	1.41	7.74	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	25.22	0.00	0.00	9.34	1.87	4.67	1.87	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.58	35.55	0.52	0.00	9.79	1.55	6.70	0.52	4.12	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	22.60	28.55	0.00	1.19	7.14	1.19	9.52	1.19	4.76	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	39.58	29.18	0.00	0.45	7.24	1.81	7.46	1.13	8.14	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	39.55	29.96	0.29	0.87	9.31	0.58	2.91	0.87	6.69	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.06	31.96	0.00	0.45	4.95	1.80	7.20	0.45	3.15	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	61.65	49.99	0.00	1.63	11.65	1.90	11.92	1.90	9.21	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.41	29.27	1.03	1.03	12.32	1.03	12.32	2.57	6.68	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.76	31.76	0.00	0.71	5.29	1.76	4.23	1.76	2.82	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.32	24.65	0.00	1.33	4.66	2.67	3.33	0.00	6.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.94	37.19	0.00	2.04	13.24	1.53	4.08	0.00	5.60	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	27.48	25.88	0.00	0.53	6.40	0.80	4.00	1.60	4.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.14	30.04	0.00	0.57	5.67	0.94	7.75	1.13	5.48	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	33.75	0.00	1.84	10.43	2.45	3.68	0.00	5.52	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	34.25	29.36	0.00	0.00	9.79	2.45	2.45	0.82	6.52	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.61	33.74	0.21	0.62	5.21	1.46	7.71	0.21	5.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	35.59	25.50	0.28	0.84	5.04	2.80	8.13	0.84	4.48	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	35.03	0.00	0.00	7.21	1.03	10.30	2.06	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.38	23.80	0.29	0.58	5.52	1.16	7.84	0.58	4.94	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.88	21.22	0.00	0.90	5.38	1.20	4.48	0.30	5.38	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.00	27.11	0.00	0.00	4.98	1.11	3.87	1.66	2.77	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.19	42.06	0.00	0.35	8.84	2.83	9.54	2.12	8.48	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	35.03	25.08	0.37	0.37	8.48	1.11	8.48	0.74	5.53	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	23.03	0.00	0.00	2.30	2.30	4.61	2.30	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	34.92	36.07	0.38	1.92	7.29	1.92	4.61	0.38	6.14	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	38.50	32.27	0.00	0.57	6.23	1.70	4.53	1.13	7.93	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	27.90	0.00	0.00	2.46	1.64	9.03	1.64	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	38.41	33.44	0.90	1.36	8.59	0.90	7.68	2.26	6.78	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	24.42	34.47	0.72	0.72	4.31	0.00	8.62	1.44	8.62	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.90	26.14	0.00	0.00	5.23	0.00	7.47	2.24	6.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	30.84	32.70	0.00	0.74	9.29	1.11	5.57	1.86	5.20	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	28.00	0.43	0.43	5.60	1.72	7.32	0.00	3.45	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.11	25.69	0.86	0.86	9.42	0.86	5.14	2.57	5.99	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.65	29.99	1.33	1.33	5.33	0.33	3.33	2.00	5.66	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	37.41	32.58	0.60	1.21	8.45	2.41	5.43	0.00	5.43	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	29.86	29.15	0.00	0.00	4.98	2.13	3.55	2.13	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	33.68	35.06	0.00	0.69	5.50	0.34	7.56	2.06	4.81	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	46.16	26.84	0.54	0.00	7.51	3.22	5.37	1.61	6.98	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.30	37.71	0.00	0.00	6.73	4.04	5.39	0.67	8.08	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.04	37.41	0.00	0.74	8.15	0.74	6.30	0.74	5.93	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	29.07	39.54	0.00	0.00	8.14	1.16	4.65	2.33	8.14	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	30.67	39.14	0.00	1.06	4.23	1.06	3.17	0.00	15.87	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.21	37.21	0.00	0.80	6.80	1.20	5.60	1.60	5.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	61.06	37.80	0.00	1.45	6.54	1.45	5.81	3.63	6.54	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	34.49	32.96	0.00	0.77	9.96	2.30	9.96	0.00	6.13	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	55.25	42.42	0.00	1.97	11.35	1.97	6.41	0.00	5.92	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	44.22	38.58	0.94	1.88	13.17	2.82	7.53	0.00	5.65	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	42.74	36.20	1.01	1.51	3.02	2.51	8.55	0.50	8.05	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.92	41.01	0.00	0.90	9.46	3.15	11.72	1.35	4.51	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	46.47	32.70	0.00	1.72	10.33	1.72	5.16	0.00	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	40.08	37.85	0.00	0.00	9.80	3.12	8.46	2.23	5.34	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	49.66	46.53	0.00	0.78	8.99	0.78	11.34	2.74	5.87	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.92	34.97	0.00	1.98	9.24	1.98	4.62	0.66	6.60	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.88	33.21	0.00	0.52	5.19	1.04	5.19	1.04	6.23	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	52.51	45.94	0.44	1.31	9.19	2.19	10.94	2.19	4.38	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	45.29	30.19	0.00	0.00	7.83	0.00	1.68	1.12	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	44.16	34.45	0.00	0.88	9.27	2.21	4.86	1.77	3.09	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	39.34	38.19	0.00	0.77	7.33	1.54	5.79	3.09	3.86	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	36.46	25.82	0.00	0.00	6.08	0.51	5.06	1.01	8.61	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.12	28.36	0.48	0.48	5.77	1.44	5.77	0.48	4.81	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.95	41.34	0.00	0.80	6.36	0.80	7.55	1.59	6.76	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	29.17	27.34	0.00	0.00	3.04	0.00	3.04	0.61	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	26.28	0.00	0.69	6.92	2.77	4.15	0.69	4.15	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	31.92	36.86	0.38	1.14	5.32	0.00	7.98	1.14	3.04	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	24.79	26.34	0.52	0.00	3.10	0.52	8.26	0.52	4.65	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	22.37	0.00	0.60	4.23	1.21	3.63	0.00	4.84	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.20	31.06	0.00	0.95	6.02	0.32	9.82	1.58	4.44	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	31.45	0.00	2.67	4.80	1.07	4.26	0.53	3.20	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	18.96	22.99	0.00	0.00	5.17	4.02	5.75	1.15	3.45	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	27.77	31.37	0.51	2.57	5.14	1.03	4.11	1.03	5.66	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	32.54	27.59	0.00	0.71	2.83	2.12	4.95	2.12	4.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.16	30.64	0.00	1.13	5.11	0.57	6.24	0.57	3.40	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.71	32.87	0.83	1.25	4.58	0.42	8.32	1.25	2.91	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	25.06	0.00	0.78	7.05	1.57	6.26	0.78	3.13	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	14.61	19.62	0.42	0.42	2.09	0.42	4.18	1.25	2.92	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.05	29.27	0.00	0.93	5.11	2.79	6.50	2.32	3.25	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	15.39	0.67	0.67	3.35	0.00	2.68	2.01	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	12.83	23.52	0.00	1.07	4.28	0.53	5.35	0.53	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.36	23.84	0.00	1.62	2.83	0.40	5.25	0.40	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	23.86	0.00	0.00	5.51	0.00	5.51	1.84	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	24.01	0.89	0.00	6.22	1.78	3.56	0.00	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	14.25	29.63	0.00	0.57	2.85	1.14	3.42	0.57	3.42	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	38.34	0.77	2.30	0.77	0.77	2.30	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	19.15	0.00	0.55	4.92	2.19	3.28	0.55	2.74	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.71	27.62	0.00	0.45	3.12	3.12	7.13	0.45	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.93	28.08	0.78	0.52	6.76	1.56	4.16	1.56	3.38	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	25.86	0.00	0.00	5.30	1.33	2.65	1.33	5.30	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	29.10	2.08	2.08	10.39	0.00	12.47	0.00	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.52	8.20	44.44	0.00	1.37	0.23	0.23	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	1.84	8.26	23.86	0.00	0.00	0.18	0.18	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	2.23	14.55	27.40	0.39	0.26	0.13	0.52	0.13	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	3.72	2.12	0.00	0.00	0.00	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.40	14.10	12.36	0.95	1.11	0.48	4.12	0.16	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	9.87	13.20	5.98	0.28	0.69	0.42	4.31	0.14	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	10.56	26.01	7.37	0.10	1.49	0.00	5.28	0.10	0.40	0.20
Mammary Epithelial Cell, donor2	11350-117G9	8.40	28.38	5.21	0.29	0.58	0.29	4.05	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.49	30.93	1.00	0.00	0.25	0.50	1.25	0.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	14.91	12.88	47.46	0.00	0.68	0.00	0.68	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	30.06	22.60	71.05	0.54	1.30	1.08	0.11	0.43	0.11	0.00
Mast cell, donor2	11565-120D8	61.22	18.72	48.74	4.46	8.62	6.24	0.30	0.30	1.49	0.59
Mast cell, donor3	11566-120D9	84.42	17.33	54.71	4.50	15.53	9.23	0.23	1.13	4.05	0.23
Mast cell, donor4	11567-120E1	76.94	16.31	38.83	2.48	13.47	6.03	0.18	1.06	1.77	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	33.27	21.51	109.78	0.55	0.78	0.33	1.11	0.44	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	21.60	26.27	95.14	0.00	0.00	0.58	1.17	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	25.12	25.70	60.23	0.46	0.69	0.46	0.23	0.57	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	43.85	43.85	81.34	1.17	2.01	1.51	0.84	0.33	1.00	0.00
Melanocyte - dark, donor1	11502-119F8	16.12	10.94	0.90	1.29	1.29	0.70	1.39	0.20	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	18.00	6.92	2.77	0.69	1.38	0.35	0.00	0.00	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	18.11	35.13	5.00	1.01	4.71	0.72	0.43	0.80	0.43	0.07
Melanocyte - light, donor1	11274-116H5	14.10	15.28	11.28	0.71	5.17	0.71	0.24	0.24	0.47	0.24
Melanocyte - light, donor2	11351-117H1	18.43	28.66	10.24	1.36	5.46	2.05	0.68	1.36	0.68	0.00
Melanocyte - light, donor3	11423-118G1	11.27	11.27	5.20	0.00	1.73	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.95	20.93	2.71	0.83	1.98	0.31	0.21	0.52	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	5.65	16.94	7.26	1.08	2.96	0.00	0.00	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	18.48	10.98	4.55	2.68	9.11	1.07	0.27	0.54	0.00	0.27
Meningeal Cells, donor1	11493-119E8	23.57	49.62	3.23	0.25	2.48	0.25	1.12	0.25	0.74	0.12
Meningeal Cells, donor2	11573-120E7	28.61	22.45	0.88	0.44	1.32	0.44	0.44	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	17.52	37.25	1.87	0.00	1.30	0.33	0.73	0.82	0.57	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	20.53	18.54	4.85	0.29	2.28	1.43	0.29	0.57	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.84	4.93	3.42	2.01	4.83	1.41	0.00	0.10	0.91	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	2.63	9.20	1.31	0.00	0.00	0.00	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	20.93	3.92	0.00	0.00	1.31	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	5.02	15.07	3.59	0.00	0.00	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	31.98	8.26	2.75	3.18	1.06	0.85	0.85	0.21	1.91	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.61	6.03	3.02	1.51	2.51	0.50	0.50	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.16	34.28	7.47	1.32	1.98	0.88	2.20	0.44	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.77	43.10	4.38	0.00	2.19	2.19	0.73	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.84	27.42	2.46	0.61	1.84	1.23	0.41	0.00	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.22	6.51	3.60	2.49	4.16	1.94	0.00	0.14	2.08	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.91	8.55	1.49	2.60	1.12	1.49	1.12	0.00	1.12	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.45	6.97	2.76	2.89	3.29	1.05	0.26	0.66	0.92	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	1.78	6.23	4.15	2.67	1.48	0.00	0.00	1.48	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	2.34	7.01	0.00	4.67	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	35.22	7.04	3.84	1.92	0.00	1.92	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	3.90	14.89	2.48	0.35	0.35	0.00	0.35	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	22.20	2.50	2.81	0.63	1.56	0.63	0.31	0.94	1.25	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	21.77	5.81	0.00	0.73	0.73	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	20.95	4.24	5.30	0.27	1.06	0.80	3.45	0.27	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	12.51	3.00	2.00	0.00	1.50	0.50	3.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.07	5.78	3.40	0.43	1.01	0.65	1.16	0.51	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	6.75	5.40	0.00	1.35	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	4.19	6.65	25.12	0.00	0.49	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.24	8.83	18.85	0.29	0.29	0.29	1.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	3.46	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	4.03	4.03	20.46	0.62	0.00	0.31	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.49	3.32	17.42	0.00	0.00	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	6.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	3.50	6.26	20.27	0.25	0.00	0.25	0.75	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.19	4.65	16.76	0.47	1.40	0.00	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.66	5.08	18.70	0.20	0.81	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	1.98	6.34	20.99	0.00	0.40	0.00	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	3.54	18.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.76	7.22	22.04	0.00	0.00	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2.97	5.09	15.07	0.00	1.06	0.21	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	4.60	5.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.79	5.96	17.29	0.00	0.30	0.00	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	1.68	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.26	5.02	13.05	0.00	0.00	0.00	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	2.38	6.65	14.50	0.00	0.00	0.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	2.76	2.76	0.00	0.00	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.15	2.76	10.82	0.00	0.46	0.00	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.89	4.42	12.41	0.00	0.00	0.21	0.63	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.22	4.89	7.13	0.20	0.20	0.00	0.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.50	3.00	11.16	0.00	0.21	0.43	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.89	3.56	8.00	0.00	0.22	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.44	2.19	6.57	0.22	0.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	1.01	2.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	3.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.82	1.90	7.88	0.00	0.00	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1.18	2.06	5.59	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.48	2.40	5.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	2.00	3.60	5.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	1.37	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.00	1.50	7.01	0.00	0.00	0.00	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	1.75	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	1.10	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.64	5.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	1.49	3.22	8.18	0.00	0.00	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	4.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.42	5.13	16.41	0.00	0.00	0.34	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.44	3.50	4.81	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.71	3.20	7.81	0.00	0.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2.52	3.37	15.71	0.28	0.00	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	3.74	6.23	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	2.91	4.08	0.00	0.00	0.00	0.58	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.71	3.92	15.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1.67	5.84	15.44	0.00	0.00	0.00	1.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	2.77	7.39	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.57	3.98	16.50	0.00	0.00	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.93	2.90	11.75	0.14	0.55	0.00	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.07	5.96	18.14	0.26	0.00	0.00	0.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.43	3.00	12.44	0.00	0.00	0.00	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	1.91	12.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.20	4.27	10.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.89	6.88	19.16	0.00	0.30	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.98	2.54	10.17	0.42	0.14	0.14	0.00	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.46	3.82	12.42	0.32	0.00	0.00	0.00	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.33	5.53	20.34	0.22	0.00	0.22	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	3.03	12.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.69	5.40	16.19	0.00	0.00	0.00	0.28	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	3.20	7.13	25.32	0.00	0.00	0.00	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1.30	0.65	11.08	1.30	0.65	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	4.41	4.12	16.76	0.00	0.00	0.29	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	3.17	6.05	24.80	0.29	0.29	0.86	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.48	7.01	28.85	0.41	1.24	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	3.87	4.17	21.14	0.30	0.60	0.60	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	3.56	10.69	0.00	1.78	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	5.91	6.57	27.93	0.33	0.33	0.00	0.66	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	8.42	23.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.71	4.35	21.75	0.40	1.98	0.40	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	3.73	14.90	0.00	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	3.38	24.41	0.38	0.38	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.20	2.13	17.58	0.00	0.00	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.75	3.73	21.72	0.11	0.34	0.00	0.11	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	3.68	19.15	0.00	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.86	4.76	21.25	0.00	0.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	1.56	26.45	0.00	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.53	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	11.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	4.04	20.20	0.00	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	1.69	4.22	0.00	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.64	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	3.02	0.00	0.00	0.00	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	22.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	13.05	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	19.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.43	7.54	1.94	0.43	1.72	0.86	0.22	0.00	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	34.49	3.14	4.70	3.66	3.14	3.14	0.00	2.09	2.09	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.01	8.01	2.00	0.67	0.67	0.67	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.34	7.51	2.92	0.42	0.00	0.00	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.06	20.35	4.75	0.76	1.90	0.57	0.57	0.00	0.57	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	17.55	1.60	6.38	0.00	0.00	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	3.40	2.04	0.00	0.00	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	22.05	3.68	5.51	0.00	1.84	0.00	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	2.93	4.19	2.09	0.00	0.84	0.00	0.00	0.84	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.67	9.07	3.02	1.63	0.46	0.23	0.46	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.43	4.86	4.05	3.24	1.08	1.62	0.00	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.28	12.82	5.68	6.52	1.89	2.31	0.00	0.00	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.85	4.96	8.93	2.48	0.99	0.99	0.00	0.50	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.95	4.60	4.06	9.47	0.81	1.62	0.00	0.00	1.89	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.47	2.49	3.85	2.49	0.45	1.13	0.00	0.00	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.86	2.29	3.59	3.76	0.49	0.98	0.00	0.49	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.89	4.01	7.11	8.57	2.00	2.55	0.00	0.18	0.91	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.63	2.12	1.59	6.90	1.59	2.65	0.53	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	1.80	4.20	1.80	0.60	3.60	0.00	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	33.80	6.89	5.58	11.16	2.63	2.63	0.00	0.33	2.63	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.73	1.46	1.79	3.42	0.65	1.63	0.16	0.33	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	27.34	5.82	6.53	7.58	0.88	4.06	0.00	0.35	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.88	2.11	2.81	4.22	0.70	0.70	0.00	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	2.76	3.22	8.27	0.46	1.38	0.00	0.00	0.92	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	2.89	4.82	4.50	0.32	3.21	0.00	0.32	1.29	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.97	5.86	0.69	6.21	1.38	2.41	0.00	0.00	3.79	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	5.06	2.53	5.06	5.06	2.53	0.00	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	15.59	3.56	4.68	6.46	0.89	2.67	0.22	0.67	2.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	0.85	2.54	5.93	0.85	1.27	0.42	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.19	3.56	4.03	6.17	0.71	2.14	0.00	0.24	1.42	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	3.43	3.00	2.15	0.86	1.72	0.00	0.43	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	3.00	3.00	1.67	1.33	1.00	0.00	0.33	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.98	2.25	4.06	3.61	0.00	1.80	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.51	0.40	2.78	1.98	1.59	0.00	0.79	0.40	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	0.93	5.57	6.50	0.00	0.00	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.54	4.54	3.03	3.41	0.76	1.51	0.00	0.38	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.12	1.63	1.96	0.98	0.33	1.96	0.00	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	0.87	1.31	1.74	0.00	2.18	0.00	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.31	1.36	4.52	4.07	1.36	0.90	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	0.00	3.53	1.76	0.88	2.65	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	3.32	2.66	1.99	0.00	0.66	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	3.47	2.48	4.96	1.49	2.98	0.50	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	0.77	1.53	1.15	0.38	0.38	0.38	0.38	1.15	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	31.45	5.75	6.05	11.80	3.33	3.02	0.30	0.30	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.26	3.76	7.51	3.54	3.54	1.33	0.00	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	2.03	0.68	2.71	1.36	1.36	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	0.00	5.11	20.44	0.00	0.00	0.00	0.00	5.11	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	1.22	1.83	2.44	1.83	1.83	0.00	0.00	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.87	2.83	1.26	0.94	0.63	0.63	0.00	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.20	2.12	1.21	3.03	0.00	2.12	0.00	0.30	0.30	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	0.00	4.75	4.75	2.37	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	6.80	4.53	5.67	4.53	1.13	0.00	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	5.06	5.06	15.17	0.00	5.06	0.00	0.00	20.23	0.00
Myoblast, donor1	11241-116D8	7.95	4.84	8.70	0.75	0.25	0.37	0.37	0.00	0.25	0.37
Myoblast, donor2	11322-117D8	22.06	9.78	6.14	1.34	1.92	1.15	0.19	0.00	0.58	0.38
Myoblast, donor3	11398-118D3	13.62	10.59	12.11	1.68	0.67	0.50	0.50	0.00	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	50.78	0.00	0.00	0.00	0.00	2.19	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	65.81	20.91	25.22	3.08	4.61	11.69	1.23	6.15	3.38	0.31
Natural Killer Cells, donor2	11311-117C6	38.90	14.78	7.24	2.41	1.81	6.33	1.21	5.73	1.51	0.60
Natural Killer Cells, donor3	11387-118C1	42.70	22.64	20.25	2.21	4.23	9.57	2.02	5.52	2.58	1.47
Neural stem cells, donor1	11275-116H6	40.29	52.99	12.34	11.61	5.08	1.45	0.00	0.00	0.36	1.45
Neural stem cells, donor2	11352-117H2	40.44	59.69	3.85	9.63	0.00	0.00	1.93	1.93	1.93	3.85
Neurons, donor1	11494-119E9	22.76	18.21	0.00	5.69	1.14	0.00	1.14	7.97	0.00	2.28
Neurons, donor2	11574-120E8	39.19	21.14	3.52	5.50	0.66	1.54	1.10	6.16	0.44	2.20
Neurons, donor3	11655-122E8	32.06	13.98	0.00	5.76	1.64	0.00	0.82	4.11	1.64	2.47
Neutrophils, donor1	11233-116C9	12.99	8.35	5.57	0.93	0.00	2.78	0.00	7.42	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	8.70	8.70	0.00	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	16.49	4.89	4.28	0.61	0.61	4.28	0.00	5.50	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	68.99	3.56	11.99	4.04	5.70	2.61	0.12	0.12	4.04	1.78
Nucleus Pulposus Cell, donor2	11409-118E5	27.03	4.23	5.86	1.63	7.49	0.98	0.00	0.33	0.98	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	12.63	2.01	3.61	1.00	2.61	1.00	0.60	0.20	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	36.75	4.54	8.40	1.10	4.27	3.30	0.28	0.28	1.79	0.28
Olfactory epithelial cells, donor2	11934-125I8	24.03	6.80	12.88	0.58	3.91	1.30	0.29	0.14	1.45	0.14
Olfactory epithelial cells, donor3	11935-125I9	35.64	4.77	9.65	0.91	3.52	2.72	0.45	0.00	2.50	0.00
Olfactory epithelial cells, donor4	11936-126A1	37.01	9.64	10.23	1.46	4.29	2.34	0.49	0.49	2.82	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	26.48	13.84	6.02	0.00	0.00	1.20	1.81	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	25.74	4.25	3.40	2.98	1.06	1.49	0.00	0.43	1.91	0.43
Osteoblast - differentiated, donor2	11353-117H3	11.43	2.29	0.00	4.57	2.29	0.00	0.00	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	5.59	3.72	3.10	0.62	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	42.02	17.20	1.37	1.56	4.89	1.37	0.59	0.59	2.54	0.39
Osteoblast, donor2	11354-117H4	23.18	23.88	2.81	3.51	0.70	2.11	0.70	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	16.53	17.42	2.13	1.07	1.42	0.89	0.53	0.36	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	42.45	14.49	7.41	3.20	3.12	1.26	0.59	0.25	3.12	0.34
Pericytes, donor1	11491-119E6	44.62	8.12	3.34	4.67	9.79	1.11	0.00	0.56	1.89	0.78
Pericytes, donor2	11571-120E5	32.82	6.79	2.49	4.75	6.79	1.81	0.23	0.68	1.58	0.45
Pericytes, donor3	11652-122E5	20.34	9.36	4.07	0.61	0.81	0.41	0.20	0.20	0.20	0.41
Perineurial Cells, donor1	11499-119F5	24.07	17.52	2.37	0.79	2.37	0.90	0.23	0.34	0.68	0.68
Perineurial Cells, donor2	11579-120F4	33.58	11.96	4.05	1.29	2.12	0.55	0.64	0.46	2.58	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	58.01	14.34	22.63	5.10	6.69	12.75	1.91	1.91	2.23	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.12	8.57	15.67	0.98	4.16	5.88	0.49	1.22	0.49	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	37.14	16.95	12.68	2.07	4.27	8.28	1.16	1.94	1.42	1.04
Placental Epithelial Cells, donor1	11278-116H9	15.07	21.29	2.87	0.48	1.67	1.20	2.15	1.20	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	33.27	26.61	5.54	1.11	1.11	0.00	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	25.33	25.13	0.79	0.79	2.16	0.79	1.37	0.79	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.23	2.22	2.53	0.95	0.00	1.58	0.63	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	21.20	3.75	2.81	3.19	1.50	1.31	0.75	0.56	1.31	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	61.61	11.49	6.66	5.48	3.92	3.79	0.78	0.91	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	21.84	4.95	1.80	2.70	0.68	2.03	0.23	0.23	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	27.49	4.26	1.60	2.24	2.66	1.81	0.43	0.64	1.07	0.75
Preadipocyte - omental, donor2	11329-117E6	23.13	3.06	3.49	2.62	1.75	2.18	0.00	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	16.47	4.15	1.00	2.15	1.58	1.00	0.57	0.29	0.57	0.14
Preadipocyte - perirenal, donor1	11469-119C2	10.83	8.86	0.98	0.98	0.98	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	20.58	13.51	5.53	1.54	0.31	3.07	0.61	0.00	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	12.75	22.31	5.31	1.24	0.00	0.35	0.35	0.53	1.06	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	10.73	7.49	1.70	1.02	0.34	1.02	0.17	0.00	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	20.21	26.45	9.59	2.42	0.47	0.56	0.47	0.19	2.05	0.00
Preadipocyte - visceral, donor2	11357-117H7	9.20	20.25	11.04	0.92	0.00	1.38	0.00	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	11.18	13.48	3.66	0.84	0.31	0.21	0.73	0.31	0.42	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	6.79	35.90	1.81	0.00	0.15	0.00	4.37	0.91	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	9.21	7.04	3.11	0.41	1.62	0.54	3.52	0.00	0.14	0.14
Prostate Epithelial Cells, donor3	11404-118D9	4.96	7.90	3.67	0.24	1.41	0.24	1.84	0.55	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	19.25	21.64	5.13	1.94	0.91	0.57	0.91	0.46	0.68	0.34
Prostate Stromal Cells, donor2	11332-117E9	12.55	18.83	2.87	1.43	0.36	0.90	0.36	0.36	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	16.37	5.11	2.92	4.28	1.25	0.63	0.21	0.10	1.04	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	16.06	23.72	3.65	0.00	1.82	0.36	2.55	1.09	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.66	16.91	3.40	0.21	1.80	0.21	2.01	0.49	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	14.71	29.42	3.55	0.00	1.52	1.01	3.04	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.92	24.90	2.13	0.00	0.71	0.00	3.56	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.21	14.93	5.61	0.11	4.02	0.53	2.75	0.85	0.95	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	14.98	6.13	0.68	2.04	0.68	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.38	18.87	7.14	0.67	1.08	1.08	0.81	0.54	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.32	21.98	4.44	0.89	0.67	0.67	1.33	0.89	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	7.32	2.66	1.33	2.00	0.67	0.67	1.33	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	30.15	18.93	3.52	0.22	4.62	1.98	1.54	0.00	0.44	0.22
Renal Mesangial Cells, donor2	11598-120H5	29.47	22.57	7.52	0.63	3.76	1.88	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	16.92	10.54	0.83	0.00	2.50	1.39	3.33	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.32	31.14	2.42	0.27	0.00	0.54	2.42	0.81	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.33	15.60	2.95	0.00	0.42	0.42	1.69	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.85	34.52	6.36	0.19	2.12	0.00	2.51	0.19	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	16.08	26.71	2.59	2.07	0.78	0.52	1.30	0.26	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.93	32.40	0.57	10.80	4.26	1.71	3.13	0.28	2.27	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	31.90	1.03	4.12	0.00	1.03	2.06	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.08	9.28	3.76	11.54	3.26	1.25	0.25	0.50	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	39.02	13.76	7.62	4.41	4.41	3.61	0.67	4.41	2.27	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	41.10	7.15	1.79	0.00	3.57	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.32	73.75	18.16	2.75	3.85	0.55	1.65	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	47.56	15.66	2.32	2.90	0.00	0.58	0.00	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.83	47.33	3.12	1.04	2.73	0.65	1.56	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.02	35.85	2.78	0.89	2.09	0.20	0.99	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.18	51.08	6.92	2.12	3.23	0.22	1.12	0.00	0.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	13.52	53.71	3.35	0.62	2.48	0.50	1.61	0.00	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	11.30	43.59	2.80	1.17	1.86	0.58	1.40	0.23	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.49	52.47	3.47	1.39	2.08	0.23	1.62	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.27	38.06	3.42	1.37	1.64	0.55	0.96	0.00	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	10.89	39.63	1.51	0.91	1.97	0.61	1.82	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.39	44.80	3.23	1.61	0.72	1.08	0.36	0.18	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.48	43.18	2.73	1.58	1.72	0.57	1.00	0.00	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.52	37.67	3.65	1.40	1.61	0.75	1.18	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.29	40.05	4.65	1.33	1.11	0.44	0.00	0.00	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.46	46.07	2.87	0.57	1.72	0.19	0.57	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	10.25	40.34	1.77	1.30	1.96	0.28	1.30	0.28	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	16.16	56.56	7.14	1.13	3.95	0.38	1.50	0.19	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.69	37.95	2.79	0.66	1.33	0.53	0.80	0.13	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	10.90	43.12	2.04	0.97	1.65	0.39	0.88	0.10	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.69	40.87	3.63	1.34	2.10	0.76	0.19	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	6.94	36.95	2.46	0.96	0.75	0.21	1.07	0.21	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.77	48.21	2.24	0.84	1.68	0.84	1.96	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	13.16	41.19	2.91	0.68	1.88	0.68	1.03	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.11	35.37	2.92	0.36	1.28	0.73	1.46	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.59	41.33	4.05	0.86	1.84	0.37	1.35	0.25	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	13.30	51.18	4.03	1.21	1.75	0.27	1.61	0.00	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.20	44.82	3.77	1.65	0.00	0.94	0.94	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.50	45.04	3.57	1.19	2.18	0.20	1.19	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.73	48.17	2.10	1.64	2.34	0.70	0.70	0.23	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	6.64	37.53	2.70	0.62	0.83	0.83	1.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	12.17	44.46	2.65	1.99	2.43	0.88	0.66	0.00	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	10.65	39.90	1.88	0.63	1.67	0.63	1.25	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.50	38.76	3.63	1.21	2.29	0.40	1.21	0.00	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.71	38.15	2.21	2.21	1.87	0.51	1.36	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.64	41.64	3.08	0.58	0.58	0.77	2.12	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.57	47.63	2.24	0.69	1.38	0.52	0.86	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	7.54	37.45	2.47	0.82	0.96	0.27	0.82	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	13.30	43.50	2.30	0.99	1.15	0.49	1.64	0.00	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.18	39.03	1.87	0.85	2.05	0.17	1.36	0.00	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.43	37.88	2.22	1.78	2.37	0.30	1.18	0.15	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	12.53	34.39	1.87	1.07	1.33	1.07	1.33	0.00	0.27	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	12.31	35.81	4.56	2.07	1.24	0.83	1.24	0.14	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.76	36.19	3.10	0.95	2.86	0.95	2.14	0.71	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	19.75	53.41	5.64	1.81	3.83	1.61	1.21	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.79	40.59	3.20	1.51	3.01	0.47	1.70	0.19	0.47	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.96	40.53	6.29	2.10	2.45	0.70	1.05	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.30	37.17	4.23	1.51	4.84	0.30	1.21	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	10.04	44.43	6.61	2.81	2.20	0.61	1.35	0.00	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	32.46	84.42	22.42	4.22	4.37	0.73	2.04	0.00	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	47.46	7.91	2.43	4.87	1.22	1.83	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.15	39.18	4.82	1.21	0.90	0.30	0.90	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	16.29	48.18	7.92	1.58	2.94	1.58	1.36	0.00	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	21.57	56.61	9.88	1.50	5.69	0.30	2.40	0.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.75	38.96	7.56	2.24	3.54	1.18	1.18	0.12	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.45	35.43	7.04	2.77	3.20	0.85	0.85	0.43	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	14.42	48.68	5.41	0.00	4.81	2.40	1.20	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	11.28	30.84	3.20	0.00	4.14	0.94	0.94	0.75	1.32	0.56
Schwann Cells, donor2	11578-120F3	10.21	20.41	3.40	0.00	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.68	21.69	3.07	0.00	1.97	0.22	0.66	0.00	1.53	0.00
Sebocyte, donor1	11220-116B5	15.89	20.27	8.76	0.00	3.83	1.64	5.48	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	12.87	17.92	2.76	0.00	1.38	0.00	2.30	0.00	1.38	0.00
Sebocyte, donor3	11378-118B1	13.40	10.10	5.98	0.41	3.30	1.03	1.65	0.00	1.03	0.00
Sertoli Cells, donor1	11255-116F4	28.16	11.60	1.66	0.00	3.31	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	2.82	0.00	0.00	0.00	0.00	0.00	0.00	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	44.96	6.69	19.36	7.21	3.26	1.23	0.09	1.06	0.88	0.70
Skeletal Muscle Cells, donor2	11358-117H8	13.01	4.34	1.45	3.61	0.72	0.72	0.00	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	15.88	49.33	10.03	1.67	0.84	0.84	0.00	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	11.94	18.85	3.30	1.10	0.47	0.79	1.41	0.31	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	11.30	22.15	3.72	1.19	0.59	0.15	0.30	0.15	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	6.16	25.39	3.54	0.62	0.62	0.15	0.92	0.46	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.49	20.67	18.40	3.78	4.03	1.26	0.38	0.25	4.28	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.68	16.84	10.42	4.00	3.00	1.57	0.43	0.29	2.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	14.29	25.89	4.27	0.79	1.29	0.10	0.40	0.40	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	43.98	8.17	4.55	11.71	4.97	1.10	0.42	0.76	1.26	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	14.48	5.07	1.45	1.45	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.56	8.12	3.16	5.64	2.89	0.96	0.28	0.00	1.65	0.41
Skin - palm, donor1	10286-104F7	8.06	16.12	2.69	2.69	2.69	5.37	8.06	2.69	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.76	3.60	1.44	0.29	0.43	0.29	2.02	0.14	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.99	62.16	12.27	1.64	8.18	2.45	2.45	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.67	7.40	3.12	0.13	0.52	0.65	2.08	0.00	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	10.15	5.70	4.03	0.42	1.81	0.42	3.48	0.14	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	5.20	4.92	5.20	0.28	0.84	0.98	1.55	0.00	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.23	61.53	15.86	0.63	3.59	2.33	7.82	0.21	1.06	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	7.05	4.42	3.45	0.15	0.52	0.30	1.57	0.52	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	3.09	1.54	6.17	0.31	0.31	0.31	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	23.34	9.12	14.90	1.11	2.67	2.45	0.44	0.22	1.11	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	9.99	13.52	0.00	1.18	0.59	0.59	0.59	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.32	7.29	8.62	0.44	1.55	0.66	0.66	0.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	17.33	7.88	3.54	0.00	0.79	0.00	0.79	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	13.13	13.91	0.00	0.77	1.55	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	59.04	5.00	3.00	25.02	4.00	2.00	0.00	0.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.97	7.05	16.63	0.67	1.20	0.13	0.67	0.40	0.53	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	14.63	6.21	3.32	0.44	0.89	0.66	0.22	0.22	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.23	2.94	4.87	0.38	0.77	1.15	0.26	0.00	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.88	7.49	3.26	0.65	1.63	0.98	0.00	0.00	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.15	8.56	3.84	0.89	1.48	0.00	0.30	0.00	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.54	5.84	2.42	0.14	1.14	1.00	0.00	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	16.59	16.43	4.55	1.14	0.81	0.81	0.49	0.33	0.81	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.09	2.74	1.83	4.87	0.91	0.61	0.00	0.30	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	38.89	13.13	2.78	1.52	2.02	1.77	0.25	0.51	2.02	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.58	4.29	7.15	0.00	0.00	0.48	0.48	0.00	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.57	9.29	6.19	1.77	0.44	0.15	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.22	9.26	3.66	3.44	1.29	0.43	0.00	0.00	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.18	15.01	3.57	1.78	0.63	0.73	0.31	0.10	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	15.16	8.66	5.88	0.46	0.93	0.46	0.62	0.00	0.77	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	4.31	1.08	0.00	1.08	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.67	6.57	6.57	0.30	0.00	0.30	0.30	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.73	23.90	1.37	4.78	1.02	1.02	0.00	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	59.53	7.22	8.95	9.11	8.72	2.43	0.31	0.24	6.67	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.50	5.94	9.96	0.70	2.11	1.11	0.20	0.00	1.11	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.34	7.28	6.83	0.46	0.68	0.46	0.23	0.00	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	7.85	5.43	0.00	1.21	0.60	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.92	25.17	1.06	1.06	0.53	0.00	1.59	0.26	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.23	15.85	3.99	2.00	1.33	0.67	0.27	0.40	2.00	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.53	5.38	4.01	5.38	0.75	1.50	0.00	0.13	0.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	4.31	1.52	5.07	0.76	1.52	0.51	0.25	2.03	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	20.81	13.12	4.37	1.51	2.56	1.21	0.75	0.15	1.51	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	9.75	2.25	1.50	0.00	0.75	0.75	0.00	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	15.51	12.92	0.00	0.00	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.49	16.74	4.65	1.40	1.86	2.79	0.93	0.00	3.26	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.10	6.56	11.11	1.51	1.51	1.01	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.78	4.39	5.64	0.63	1.57	0.94	0.00	0.31	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	6.19	2.65	1.47	1.47	1.18	0.29	0.00	2.95	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.41	20.83	2.58	0.25	0.50	0.58	0.92	0.17	0.25	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.89	5.61	1.40	8.88	0.93	1.40	0.00	0.47	0.47	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	11.23	7.63	12.38	0.72	0.43	1.01	0.58	0.14	0.72	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.96	12.24	12.49	0.51	1.27	0.00	0.25	0.51	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.77	11.09	3.20	1.13	1.13	0.56	0.19	0.19	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.62	24.46	7.83	2.10	2.38	1.12	1.26	0.14	1.12	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.89	4.02	4.78	1.59	2.09	0.25	0.34	0.42	0.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	3.81	2.86	0.48	1.43	1.43	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.25	7.34	10.77	0.73	1.22	0.98	0.24	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.59	2.87	1.99	0.22	0.00	0.88	0.44	0.22	1.10	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.90	19.02	4.68	0.88	1.46	1.46	0.88	0.29	2.34	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	34.21	3.30	3.50	10.69	1.75	0.78	0.00	0.78	1.94	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	1.32	3.70	0.26	0.26	1.85	0.00	0.00	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	30.50	7.44	4.46	6.32	1.49	2.60	0.00	0.00	2.23	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	5.03	8.26	4.31	1.80	1.44	0.00	0.00	1.80	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.06	4.83	6.53	1.14	0.85	1.14	0.57	0.00	1.99	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.60	28.75	6.30	1.18	1.58	0.79	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	17.01	6.60	6.60	4.57	1.02	1.02	0.25	0.25	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	18.37	3.59	4.79	4.79	2.00	2.00	0.00	0.40	3.99	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	13.79	2.93	3.34	5.85	2.09	2.93	0.00	0.84	2.93	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	22.00	3.67	1.83	8.25	1.38	1.38	0.46	0.00	2.75	0.92
Synoviocyte, donor1	11291-117A4	19.02	6.73	7.24	1.01	1.18	1.35	0.17	0.50	1.51	0.17
Synoviocyte, donor2	11368-117I9	17.43	2.18	8.21	3.18	0.34	1.68	0.17	0.17	0.34	0.67
Synoviocyte, donor3	11440-118H9	19.88	2.68	7.82	2.46	0.22	2.23	0.00	0.22	1.79	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	26.80	62.18	5.72	6.79	2.50	0.00	1.43	0.71	1.79	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	7.93	23.78	1.98	0.00	0.00	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.90	19.45	4.17	3.24	3.47	1.16	0.46	0.23	0.46	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	10.11	13.91	2.65	0.00	2.65	0.14	1.86	0.22	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	10.82	1.93	0.00	0.00	0.39	1.16	0.00	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	7.44	1.72	0.00	0.57	0.00	2.29	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	44.17	16.98	8.24	3.44	5.17	4.31	1.23	4.67	2.95	1.11
Urethra, donor2	10319-105A4	34.17	17.98	10.79	21.58	1.80	5.40	0.00	1.80	3.60	1.80
Urothelial Cells, donor1	11520-119H8	13.02	14.61	4.25	0.27	1.86	0.27	2.13	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	17.62	12.02	2.00	0.00	2.80	1.20	2.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	11.23	10.77	3.67	0.00	2.06	0.69	2.98	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	18.05	14.04	4.24	0.00	4.24	0.45	2.90	0.45	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	43.60	5.34	16.02	0.89	2.67	17.80	1.78	2.67	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	10.01	21.44	0.00	1.43	14.30	0.00	2.86	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.75	8.21	7.53	2.74	0.68	6.85	0.00	1.37	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	63.70	6.89	22.04	2.07	2.41	15.84	1.03	2.75	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	62.75	9.88	21.50	2.32	1.74	11.04	1.16	1.74	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	11.45	16.66	0.00	1.04	11.45	0.00	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	10.10	27.53	2.75	2.75	7.34	0.00	1.84	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	33.78	10.04	9.13	3.65	1.83	3.65	2.74	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.72	34.29	0.74	0.99	0.49	0.00	1.73	0.12	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	6.16	10.56	0.00	3.52	0.88	0.88	0.88	2.64	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	0.00	82.12	0.00	0.00	0.00	0.00	13.69	0.84	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	10.33	10.33	2.07	0.00	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	30.34	72.66	0.51	0.51	0.51	1.27	1.78	0.25	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	32.04	86.14	2.79	69.19	2.32	0.70	2.32	0.70	2.09	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	23.62	123.34	0.36	1.66	1.19	2.02	10.21	0.47	2.26	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.25	42.72	0.00	0.00	0.00	0.00	2.45	0.54	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	7.59	52.28	0.56	0.00	0.56	1.12	1.69	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.21	43.14	5.08	0.63	0.42	0.85	1.06	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	19.33	38.38	32.39	1.91	4.90	2.99	1.63	0.00	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	19.39	57.28	3.08	0.44	0.44	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.64	48.19	8.17	0.00	2.45	2.86	1.63	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.19	63.29	5.44	0.00	0.00	0.00	1.16	0.39	1.16	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.31	37.54	0.55	0.00	0.18	0.18	2.58	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	46.81	3.90	3.90	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.82	54.84	1.39	0.70	0.70	0.70	4.18	0.23	0.93	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.09	65.76	1.81	0.26	0.52	0.52	3.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	15.20	56.99	1.46	0.00	1.75	0.29	0.58	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.93	31.14	9.30	0.00	0.00	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	34.55	20.97	0.00	0.00	0.00	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	11.66	4.91	0.00	0.00	0.00	1.84	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.00	54.62	19.20	0.00	0.00	0.00	2.13	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.00	46.71	18.20	0.00	0.00	0.00	1.21	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.00	53.92	17.33	0.00	0.00	0.00	0.48	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	43.88	1.11	0.00	0.00	0.00	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	3.67	41.36	6.34	0.00	0.00	0.00	1.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	33.45	0.00	0.00	0.00	0.00	1.86	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.53	54.24	0.00	0.00	1.13	0.38	1.13	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	11.78	56.70	9.16	0.44	0.00	0.00	3.49	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	31.87	5.62	0.00	0.00	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.60	20.96	0.00	0.00	0.00	0.00	6.59	0.94	2.35	0.94
adipose tissue, adult, pool1	10010-101C1	56.93	7.45	10.70	7.45	1.40	3.26	0.62	4.81	1.55	1.24
adipose, donor1	10184-103D4	16.42	95.58	0.59	48.09	2.35	0.00	2.93	2.35	1.76	0.59
adipose, donor2	10185-103D5	12.17	17.84	0.81	17.84	0.41	0.00	0.41	4.06	0.81	0.00
adipose, donor3	10186-103D6	18.52	31.59	1.63	8.71	0.54	1.09	1.63	0.27	1.09	0.82
adipose, donor4	10187-103D7	26.00	23.40	0.00	3.47	0.87	1.73	4.33	0.00	3.47	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.42	42.14	0.00	1.74	0.63	0.00	1.89	0.63	0.79	0.63
adrenal gland, adult, pool1	10081-102A9	50.93	0.00	10.91	0.00	0.00	0.00	0.00	3.64	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	7.07	49.23	7.07	0.00	0.93	0.13	2.00	0.67	0.67	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	6.43	62.88	6.43	0.00	1.07	0.00	1.07	1.79	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	28.75	14.14	11.59	0.00	3.71	1.16	3.48	1.85	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	37.53	22.99	7.10	0.34	3.38	1.01	4.73	0.68	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	40.36	11.78	11.78	0.29	9.43	3.83	2.65	1.47	2.65	0.00
amygdala - adult, donor10196	10167-103B5	14.23	4.74	2.37	8.30	0.00	5.93	0.00	2.37	1.19	3.56
amygdala, adult, donor10252	10151-102I7	31.63	19.26	3.85	12.77	7.10	8.92	0.81	10.95	3.65	4.66
amygdala, newborn, donor10223	10360-105E9	12.27	9.36	2.90	5.16	1.29	1.29	0.65	3.87	0.97	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	44.44	16.43	5.22	1.40	12.35	3.18	0.51	0.76	3.31	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	31.55	5.96	0.00	0.00	0.00	1.76	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	24.05	68.81	0.67	2.67	13.03	6.01	9.69	0.33	4.68	2.00
aorta, adult, pool1	10052-101G7	45.11	10.98	7.85	5.10	7.65	8.63	0.00	10.98	1.37	2.94
appendix, adult	10189-103D9	43.47	17.47	3.88	10.87	4.27	7.76	1.94	1.55	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	23.04	30.95	0.00	1.38	0.00	1.03	5.50	0.69	0.69	0.00
artery, adult	10190-103E1	35.33	8.15	2.72	13.59	2.72	10.87	0.00	9.51	2.72	2.72
astrocytoma cell line:TM-31	10425-106D2	40.71	50.41	49.83	3.77	3.62	3.91	5.22	0.14	0.29	0.14
b cell line:RPMI1788	10427-106D4	20.67	31.52	6.54	0.00	0.74	0.00	3.27	0.15	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.37	6.94	5.83	0.28	0.28	1.66	0.00	0.00	1.11	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	16.37	58.55	2.38	0.30	1.29	0.30	5.16	0.40	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	11.55	8.54	7.20	0.33	0.67	0.33	1.67	1.00	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	34.67	27.96	0.00	0.00	0.56	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	34.55	19.45	16.51	18.25	3.04	8.15	0.65	6.52	2.17	2.82
blood, adult, pool1	10053-101G8	13.29	2.21	11.07	2.21	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	9.42	5.99	0.00	0.00	0.00	0.00	0.00	1.71	0.00
bone marrow, adult	10192-103E3	45.89	14.85	12.82	11.47	2.70	3.37	0.00	0.67	1.35	0.00
brain, adult, donor1	10084-102B3	29.73	13.33	2.05	7.18	3.08	11.28	4.10	13.33	1.03	5.13
brain, adult, pool1	10012-101C3	24.72	14.25	2.34	8.80	7.57	5.90	1.34	8.02	2.45	6.01
brain, fetal, pool1	10085-102B4	29.39	10.69	0.00	10.69	2.67	0.00	0.00	10.69	2.67	10.69
breast carcinoma cell line:MCF7	10482-107A5	39.97	27.42	0.33	0.33	9.91	2.31	5.62	1.98	4.29	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	49.06	48.56	3.00	0.37	3.87	1.37	9.86	2.75	9.74	2.75
breast, adult, donor1	10080-102A8	29.04	9.47	5.68	6.31	1.26	1.89	0.00	5.05	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.36	28.58	2.03	0.64	2.54	0.89	6.35	0.38	0.51	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	18.55	29.99	14.53	0.00	3.71	2.47	4.95	1.24	1.86	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.85	55.94	1.84	0.00	0.00	0.00	2.30	2.07	1.84	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.93	29.29	2.18	0.00	0.73	0.48	5.57	0.48	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	8.46	36.20	0.00	4.23	0.47	0.94	2.35	1.41	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	12.36	46.16	4.92	0.55	2.84	1.09	9.41	2.41	0.77	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	14.58	22.50	0.00	0.32	1.27	0.00	0.00	0.00	0.00	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.87	82.52	1.86	10.11	2.13	1.06	0.80	0.53	1.86	0.53
caudate nucleus - adult, donor10196	10177-103C6	18.42	16.12	2.30	11.51	3.45	5.76	6.91	6.91	1.15	6.91
caudate nucleus, adult, donor10252	10164-103B2	29.62	19.58	3.18	15.39	4.52	9.87	4.69	7.20	3.51	4.69
caudate nucleus, adult, donor10258	10379-105H1	34.39	14.52	2.29	14.52	0.76	8.41	5.35	4.58	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	22.34	14.28	2.93	9.52	0.73	1.83	2.56	5.86	0.73	1.10
cerebellum - adult, donor10196	10173-103C2	37.87	40.79	0.00	11.65	8.74	11.65	2.91	34.96	2.91	8.74
cerebellum, adult, donor10252	10166-103B4	76.86	38.65	1.92	27.33	10.89	21.78	2.56	21.35	4.48	7.69
cerebellum, adult, pool1	10083-102B2	23.11	13.11	1.38	7.93	6.90	4.14	1.72	11.38	2.76	2.07
cerebellum, newborn, donor10223	10357-105E6	49.82	39.85	2.49	66.42	7.47	11.62	2.49	19.93	4.15	8.30
cerebral meninges, adult	10188-103D8	13.11	7.56	0.76	5.29	5.80	2.27	1.01	3.28	2.02	2.02
cerebrospinal fluid, donor2	10294-104G6	11.69	2.92	2.92	2.19	1.46	0.73	2.19	2.19	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	46.15	39.83	32.49	3.45	0.43	1.44	3.88	1.58	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	22.37	31.32	6.96	0.00	0.00	0.00	4.31	0.17	0.17	0.00
cervix, adult, pool1	10013-101C4	108.45	25.93	13.86	34.12	6.51	6.72	1.47	7.87	5.04	4.72
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	34.28	16.72	3.07	0.84	2.93	0.56	1.11	1.25	0.70	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	3.92	5.23	7.84	0.00	0.00	1.31	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.12	39.27	0.75	0.00	0.00	0.00	5.72	1.62	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	1.85	21.44	0.00	0.00	0.00	0.00	2.22	0.62	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	14.71	0.24	0.00	0.00	0.00	0.95	3.79	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	7.98	11.68	4.56	0.00	0.57	0.00	3.70	1.99	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	17.00	13.03	4.67	0.50	0.89	0.40	1.29	0.99	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	4.95	9.34	3.30	0.55	0.55	1.65	2.75	2.75	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	42.41	0.00	0.00	0.00	0.00	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.26	35.54	17.10	0.00	0.58	0.96	0.96	0.00	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.15	47.31	17.53	0.21	0.84	0.21	3.80	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.77	46.74	0.00	0.00	0.00	0.00	3.60	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.42	48.86	0.00	0.00	0.00	0.00	2.66	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1.43	54.57	0.41	0.00	0.00	0.00	2.04	0.81	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	1.18	65.07	0.29	0.00	0.00	0.00	2.94	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	47.69	86.53	19.55	0.52	3.65	0.52	4.95	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.00	33.37	4.57	0.00	0.00	0.00	3.20	0.00	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	9.89	41.82	1.21	0.17	2.43	0.69	4.86	1.74	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	4.21	58.39	0.37	0.18	0.00	0.00	6.77	0.92	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	6.08	46.75	1.14	0.38	0.38	0.76	4.56	1.14	0.00	0.38
colon, adult, donor1	10082-102B1	58.31	28.56	11.90	13.09	5.95	8.33	4.76	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	59.34	15.98	5.52	9.05	7.05	5.88	1.65	3.76	1.65	3.06
colon, fetal, donor1	10070-101I7	48.20	18.54	1.85	10.51	3.09	2.47	2.47	3.71	4.94	3.71
common myeloid progenitor CMP, donor1	12130-128D6	91.67	64.17	4.58	4.58	13.75	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	10.20	54.39	55.67	0.00	0.00	0.00	1.27	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.47	44.83	65.81	0.00	0.00	0.00	2.11	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	5.64	48.93	79.67	0.00	0.00	0.14	1.27	0.14	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	90.66	24.21	13.05	38.59	11.72	19.35	0.88	24.21	8.51	18.13
cruciate ligament, donor2	10295-104G7	21.88	6.48	12.97	4.86	1.62	1.62	0.00	3.24	8.10	4.86
diaphragm, fetal, donor1	10069-101I6	33.71	4.01	3.21	8.83	4.01	11.24	0.00	6.42	2.41	0.00
diencephalon, adult	10193-103E4	21.12	10.32	0.96	9.36	4.08	6.96	1.44	5.28	3.36	4.56
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	37.20	51.43	0.46	1.84	2.76	0.69	2.07	0.00	1.61	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	34.62	2.31	0.51	0.00	0.77	3.59	1.54	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.52	15.89	10.35	0.48	3.61	0.72	1.44	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	58.31	23.92	32.89	9.47	1.99	3.99	5.98	6.48	3.49	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	69.13	17.28	2.88	14.40	4.32	0.00	1.44	4.32	4.32	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	75.77	26.48	3.68	21.33	8.09	5.89	1.47	2.94	2.94	0.00
dura mater, adult, donor1	10041-101F5	34.77	22.71	22.71	6.28	3.96	1.65	0.74	4.13	1.16	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.88	42.42	0.67	0.89	0.22	0.22	0.67	2.44	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	7.59	31.81	0.00	0.72	0.29	0.14	1.29	3.01	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	3.70	14.80	0.62	0.00	0.62	1.23	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	13.62	17.56	2.42	0.00	1.51	0.30	0.00	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	9.26	18.22	6.79	0.00	1.23	0.00	0.00	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	7.88	26.27	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	5.36	18.10	10.73	0.34	1.01	0.34	2.01	0.00	0.00	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	46.40	19.39	23.74	1.09	7.07	1.27	0.91	2.17	0.72	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.01	12.38	1.77	0.48	1.77	0.00	2.41	0.48	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	3.33	23.79	0.67	0.00	0.44	0.56	2.78	0.11	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	0.33	97.56	4.51	0.00	0.00	0.00	14.96	1.10	0.00	0.00
epididymis, adult	10197-103E8	55.47	14.02	15.49	9.21	5.65	3.56	2.93	4.40	1.67	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.97	23.42	1.95	0.89	4.44	0.53	1.24	1.42	1.06	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	7.08	11.01	1.97	0.39	1.18	0.39	1.18	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	0.13	82.17	4.46	0.00	0.00	0.00	5.11	1.44	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	0.10	62.50	3.35	0.00	0.00	0.00	4.72	0.30	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	0.11	61.06	4.93	0.00	0.00	0.00	6.05	0.90	0.00	0.00
esophagus, adult, pool1	10015-101C6	31.64	23.25	13.06	7.01	4.35	3.40	3.72	3.19	2.12	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	13.78	26.42	0.13	4.76	2.38	1.25	1.63	3.26	0.38	0.25
eye - muscle inferior rectus, donor1	10272-104E2	33.80	9.66	4.83	19.32	0.00	4.83	2.41	4.83	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	10.52	2.10	10.52	10.52	0.00	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	5.95	0.00	7.44	1.49	2.98	0.00	2.98	0.00	1.49
eye - muscle superior, donor2	10297-104G9	25.22	4.59	3.44	14.90	3.44	3.44	0.00	4.59	2.29	2.29
eye - vitreous humor, donor1	10268-104D7	8.74	10.20	7.29	5.83	4.37	1.46	4.37	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	37.88	12.46	5.34	25.42	5.34	6.10	1.02	7.37	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	7.57	24.23	4.87	0.26	1.54	0.38	2.44	0.38	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.45	68.38	7.12	0.71	0.95	0.24	3.09	0.24	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	37.62	17.45	3.47	10.70	8.63	8.16	3.57	10.79	3.00	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.33	76.86	3.00	0.60	2.40	0.30	8.11	0.60	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	17.56	19.38	18.29	0.09	1.92	0.18	4.75	1.01	0.27	0.00
gall bladder, adult	10198-103E9	46.84	15.45	4.10	16.18	5.55	7.00	1.21	6.52	0.97	2.66
gamma delta positive T cells, donor1	11937-126A2	67.11	8.59	13.96	0.54	3.22	11.27	0.00	3.22	1.07	1.61
gamma delta positive T cells, donor2	11938-126A3	54.16	11.58	36.98	1.12	4.11	8.59	2.24	6.35	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.67	28.94	0.21	0.42	5.49	0.42	1.69	0.42	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	47.39	45.26	0.39	0.77	8.12	3.29	5.22	0.97	5.42	0.58
gastric cancer cell line:AZ521	10549-107H9	16.89	46.24	0.16	0.00	1.15	0.49	2.79	0.33	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	49.42	0.00	0.00	0.00	0.00	6.41	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.10	53.92	0.23	5.03	5.71	3.43	3.20	2.74	0.91	0.00
giant cell carcinoma cell line:LU65	10487-107B1	6.54	8.38	7.57	0.34	0.11	0.11	2.87	0.23	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	43.39	10.08	14.42	0.14	5.46	0.70	0.98	1.12	1.54	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.71	35.42	11.47	1.00	2.49	1.50	4.49	0.75	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.98	26.92	18.37	0.95	6.97	1.16	1.90	0.21	0.84	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.65	23.17	15.59	0.70	6.32	1.26	2.39	0.00	1.26	0.28
glioblastoma cell line:T98G	10485-107A8	17.33	42.05	5.74	1.55	3.53	0.66	1.32	0.22	0.99	0.33
glioma cell line:GI-1	10413-106B8	33.39	14.06	10.25	2.64	4.98	2.34	0.29	0.88	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	18.22	11.66	0.73	15.31	4.37	8.75	2.19	8.75	3.64	2.19
globus pallidus, adult, donor10252	10161-103A8	41.01	17.57	7.57	21.97	6.10	14.16	0.49	20.99	6.59	13.91
globus pallidus, adult, donor10258	10367-105F7	32.86	16.43	2.74	20.54	9.58	6.85	1.37	9.58	2.74	4.11
globus pallidus, newborn, donor10223	10364-105F4	15.45	5.33	4.26	6.93	0.53	2.13	0.00	4.26	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	29.37	80.76	2.45	2.45	2.45	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	43.71	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	20.91	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.60	14.08	3.84	1.28	1.60	1.28	1.60	0.64	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	6.89	31.22	0.46	0.92	0.46	0.00	0.46	0.46	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.77	32.47	1.37	1.83	0.00	0.46	1.37	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.86	25.76	0.00	0.64	0.00	0.00	1.93	0.64	0.64	0.00
hIPS, biol_rep1	14380-156B6	10.06	31.62	0.00	0.00	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	2.06	21.95	0.00	0.69	0.00	0.69	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	15.45	12.14	4.41	14.35	1.10	5.52	5.52	2.21	2.21	2.21
hairy cell leukemia cell line:Mo	10712-109I1	0.00	18.39	10.34	0.00	0.00	0.00	2.87	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	24.81	7.18	2.09	9.27	2.99	5.08	0.30	6.88	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	37.39	8.63	8.37	10.46	4.71	8.63	0.52	8.37	1.31	1.57
heart - tricuspid valve, adult	10207-103F9	7.49	9.16	2.50	3.33	1.67	0.83	0.00	1.67	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	25.30	18.16	3.26	2.65	2.65	4.29	3.06	4.49	0.00	1.02
heart, adult, diseased, donor1	10051-101G6	39.60	8.52	5.11	9.37	11.50	10.65	0.85	2.98	0.43	1.28
heart, adult, pool1	10016-101C7	14.03	3.68	2.99	3.22	1.61	3.45	0.23	2.07	0.69	0.00
heart, fetal, pool1	10046-101G1	92.10	19.41	3.70	22.38	13.66	7.19	1.13	4.62	3.29	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	4.32	5.55	0.93	3.09	1.54	0.31	0.31	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	22.59	0.00	2.38	2.38	1.19	0.00	2.38	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.61	33.48	2.98	0.44	0.33	0.55	3.65	0.44	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	10.07	31.68	1.58	0.61	0.49	0.12	4.13	1.21	0.61	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.62	38.40	1.31	0.61	0.51	0.71	3.44	0.20	0.51	0.10
hepatoma cell line:Li-7	10484-107A7	28.36	17.79	2.56	1.11	1.22	1.45	1.22	0.56	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	2.91	27.74	5.83	0.00	0.00	0.00	2.51	0.20	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	14.19	11.36	1.89	3.79	2.84	4.73	0.00	4.73	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	38.98	17.76	2.45	12.04	4.69	8.98	1.84	12.25	5.51	4.08
hippocampus, adult, donor10258	10374-105G5	7.97	12.45	0.50	8.96	3.49	3.49	2.99	1.99	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	7.40	4.93	2.82	2.11	1.41	1.06	0.00	4.23	1.06	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.99	67.75	0.00	1.22	1.22	0.00	6.10	0.00	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.11	35.54	0.00	0.59	0.00	0.20	3.34	0.39	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.89	45.19	0.00	0.76	0.00	0.25	2.54	0.51	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	13.53	46.24	0.00	16.92	0.56	0.56	1.13	1.69	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.36	65.59	0.00	14.72	1.55	1.03	1.29	0.52	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	16.70	69.85	1.14	23.92	0.00	0.38	1.90	0.38	2.28	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	18.10	72.99	0.00	7.88	1.75	0.88	1.46	0.58	2.04	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	23.27	59.03	0.00	11.20	2.15	0.86	2.80	1.29	1.08	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	21.27	62.98	0.00	10.84	1.25	0.83	2.92	1.25	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	17.05	37.41	1.18	9.95	0.71	0.71	2.37	0.47	2.37	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	21.38	50.79	0.32	8.84	1.29	0.32	1.61	1.29	0.64	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.20	40.40	0.00	5.39	0.00	0.67	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.44	32.08	0.00	0.31	0.16	0.16	0.78	0.31	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.44	39.79	0.00	0.00	0.49	0.00	1.97	0.00	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5.24	41.02	0.00	0.87	0.00	0.00	1.75	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.99	48.11	0.57	28.64	0.76	0.95	1.15	1.72	1.72	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.03	60.61	0.44	28.34	1.31	0.87	1.31	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.99	63.47	0.50	39.48	3.00	0.50	1.50	1.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.97	34.48	0.94	28.26	1.13	0.94	1.13	3.01	1.88	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	14.55	32.74	0.00	21.83	0.00	1.36	2.73	4.09	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.67	32.89	0.63	30.70	1.57	0.31	1.57	1.25	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.66	27.76	3.92	26.94	0.98	0.98	1.14	0.98	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.64	27.87	3.77	23.81	0.87	2.32	2.32	0.58	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	12.85	27.20	3.59	31.98	2.69	2.39	1.20	2.39	1.20	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.84	35.84	0.00	1.29	0.00	0.00	2.40	0.37	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.42	40.23	0.00	1.14	0.57	0.00	3.14	0.29	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	6.53	47.77	0.00	0.82	0.00	0.00	2.45	0.00	1.22	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	14.44	45.77	0.35	16.90	3.17	0.00	2.11	1.41	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.35	43.71	0.63	14.89	0.95	0.00	0.32	1.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.38	46.00	0.91	19.07	1.21	0.00	2.42	2.42	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	13.45	43.44	0.52	18.62	1.55	0.52	0.52	1.55	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.28	34.54	0.66	22.58	1.99	1.33	2.66	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.47	43.61	0.51	20.78	2.31	0.77	1.80	2.05	1.54	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	32.21	2.05	15.59	1.53	0.51	1.02	1.53	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	11.36	44.68	1.51	25.75	3.03	0.76	1.51	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.11	35.29	5.71	13.44	1.34	0.34	0.00	2.35	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	7.97	35.02	0.00	1.21	0.24	0.00	1.45	0.00	0.97	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	37.44	0.00	1.78	0.45	0.45	1.78	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	5.85	48.29	0.00	0.49	0.00	0.00	1.95	0.00	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.22	52.57	0.00	24.76	1.22	0.92	2.75	1.83	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	156.16	3.25	78.08	9.76	0.00	13.01	0.00	3.25	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.14	82.07	0.33	29.45	3.64	0.99	1.65	1.32	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.87	49.26	0.00	19.70	1.64	1.09	2.19	1.64	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	21.35	53.92	0.00	13.75	0.72	0.00	2.17	3.62	1.09	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	17.08	52.31	0.36	13.17	0.00	0.36	0.71	1.07	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	34.61	1.19	14.32	2.39	0.00	1.19	1.19	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.66	53.09	1.49	13.41	1.63	1.35	2.44	2.30	0.81	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.97	34.75	2.42	10.51	1.08	0.54	1.35	1.08	0.27	0.27
immature langerhans cells, donor1	11904-125F5	15.01	17.19	5.81	1.21	7.26	0.00	1.70	0.24	0.73	0.00
immature langerhans cells, donor2	11905-125F6	20.60	16.63	3.96	0.00	2.38	1.58	3.17	1.58	0.79	0.79
insula, adult, pool1	10039-101F3	44.00	20.72	3.79	10.22	9.56	7.76	4.64	8.52	3.12	5.68
keratoacanthoma cell line:HKA-1	10791-110H8	5.85	13.98	0.98	0.00	0.65	0.65	1.63	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	38.75	13.42	6.21	0.60	1.30	1.60	4.11	2.60	0.50	0.20
kidney, fetal, pool1	10045-101F9	132.35	33.95	3.75	16.41	6.44	3.75	5.45	7.78	2.69	0.78
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.30	16.62	14.91	0.71	2.98	0.57	1.42	0.28	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.67	4.29	5.11	0.55	1.94	0.83	0.55	0.69	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.46	56.33	0.92	0.73	0.00	0.92	6.61	0.37	1.28	0.00
left atrium, adult, donor1	10079-102A7	23.97	4.36	2.18	6.54	4.90	3.81	1.63	2.72	1.63	2.18
left ventricle, adult, donor1	10078-102A6	10.62	2.53	3.03	4.55	3.54	2.53	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	11.49	18.88	0.27	0.82	0.27	0.00	1.37	0.27	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	10.42	2.51	2.51	2.16	1.08	1.08	0.72	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	10.87	2.72	4.35	0.00	1.09	0.00	0.54	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	13.84	8.74	5.34	0.00	2.19	1.46	0.73	0.24	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	31.37	8.36	0.00	2.09	1.05	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	7.08	68.36	6.02	0.24	0.83	0.24	1.53	0.00	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	18.75	8.59	25.15	0.62	1.41	1.87	0.78	0.00	1.56	0.00
liposarcoma cell line:SW 872	10726-110A6	21.93	31.56	0.85	1.58	3.05	1.83	3.17	0.37	0.00	0.12
liver, adult, pool1	10018-101C9	19.12	5.83	3.08	2.11	2.11	1.78	0.97	1.30	1.13	0.00
liver, fetal, pool1	10086-102B5	11.29	13.17	0.94	0.94	0.94	0.00	0.94	2.82	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	24.06	13.12	3.21	6.71	3.65	4.37	1.90	7.44	1.90	5.25
locus coeruleus, adult, donor10252	10165-103B3	36.17	14.39	5.17	11.81	3.32	8.30	2.21	12.73	4.24	6.09
locus coeruleus, adult, donor10258	10375-105G6	24.26	10.44	2.26	8.46	3.39	5.36	1.13	6.49	3.39	3.95
locus coeruleus, newborn, donor10223	10362-105F2	23.55	18.09	7.99	5.05	1.26	2.10	1.26	3.79	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	11.35	8.03	8.86	0.14	1.38	1.11	1.52	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	16.55	24.13	9.65	0.00	2.76	0.00	8.96	0.00	2.76	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.71	47.06	14.76	0.26	2.90	1.05	9.62	0.66	1.19	0.13
lung, adult, pool1	10019-101D1	34.97	14.18	7.21	3.19	5.08	3.78	0.95	2.72	1.18	0.95
lung, fetal, donor1	10068-101I5	113.59	19.69	7.99	57.08	13.98	11.13	1.71	5.42	5.71	1.71
lung, right lower lobe, adult, donor1	10075-102A3	45.82	11.00	15.58	3.67	6.42	5.50	1.83	1.37	1.37	0.46
lymph node, adult, donor1	10077-102A5	19.88	6.15	6.63	1.42	3.79	7.57	0.47	0.00	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	22.79	23.67	0.00	0.00	0.00	0.88	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.02	43.92	0.15	0.75	0.91	0.60	3.47	0.15	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	32.28	2.55	0.85	2.55	0.00	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	31.97	4.44	9.32	7.99	0.44	2.66	0.00	1.78	0.44	2.22
mature adipocyte, donor2	12232-129F9	44.20	4.15	8.72	8.72	1.87	3.53	0.42	2.91	1.04	1.87
mature adipocyte, donor3	12233-129G1	45.52	4.27	7.82	5.22	1.42	2.37	0.00	3.08	1.19	1.90
mature adipocyte, donor4	12234-129G2	62.65	8.69	10.79	11.58	3.16	3.42	0.00	2.37	2.63	4.21
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.44	24.78	7.86	0.48	2.62	1.67	4.53	1.67	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	22.56	3.38	3.38	5.64	11.28	4.51	9.02	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	34.94	17.66	3.68	10.11	5.70	9.75	2.94	11.40	4.60	5.15
medial frontal gyrus, adult, donor10258	10368-105F8	20.65	11.12	1.59	9.85	5.08	6.67	1.91	4.13	2.22	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	16.21	12.79	1.28	5.97	2.99	2.13	0.85	5.54	1.71	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	22.11	16.03	1.01	9.62	5.74	6.92	1.69	8.44	2.19	5.57
medial temporal gyrus, adult, donor10252	10156-103A3	34.59	17.83	4.24	15.92	5.52	9.97	1.91	15.49	5.94	8.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	13.48	0.00	5.78	0.00	5.78	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	14.35	14.35	0.00	0.00	28.71	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	14.00	5.03	2.15	3.95	3.23	1.79	1.79	4.67	2.87	1.79
medulla oblongata - adult, donor10196	10174-103C3	16.22	10.38	2.60	6.49	2.60	3.24	0.00	5.19	2.60	2.60
medulla oblongata, adult, donor10252	10155-103A2	46.29	18.27	5.73	12.69	5.26	8.82	1.24	13.78	6.04	7.28
medulla oblongata, adult, pool1	10038-101F2	60.00	16.08	10.94	11.67	6.86	7.59	2.45	11.75	2.94	9.39
medulla oblongata, newborn, donor10223	10361-105F1	18.40	11.80	6.25	6.94	2.08	5.55	1.04	5.90	0.35	1.39
medulloblastoma cell line:D283 Med	10838-111E1	20.81	98.97	0.22	44.06	3.99	2.44	2.44	11.73	4.65	0.66
medulloblastoma cell line:ONS-76	10759-110E3	5.62	23.11	0.73	0.37	0.98	0.49	4.04	0.49	0.49	0.37
melanoma cell line:COLO 679	10514-107E1	10.21	10.21	0.14	0.29	2.44	0.57	0.14	0.86	0.00	0.14
melanoma cell line:G-361	10465-106H6	16.83	10.86	1.90	0.27	5.16	1.63	0.27	0.27	1.09	0.54
meningioma cell line:HKBMM	10691-109F7	10.31	9.59	10.13	0.18	2.71	0.90	0.72	0.90	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	33.48	118.96	0.00	14.98	0.88	0.88	14.98	2.64	3.52	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	58.07	98.25	0.00	13.74	2.07	3.63	8.04	3.37	4.41	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.09	14.73	9.82	1.07	0.46	0.61	0.46	0.15	1.38	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.36	3.64	4.36	1.64	0.18	0.36	0.00	0.00	1.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	6.63	1.66	1.24	0.00	0.83	0.41	0.00	2.90	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.00	8.15	6.18	0.98	1.40	1.40	0.42	0.00	1.12	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.87	5.01	4.81	1.35	0.00	1.73	0.19	0.00	1.16	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	6.94	9.02	3.47	0.00	2.78	0.00	0.00	0.69	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.90	3.78	11.67	0.86	0.34	0.34	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.10	7.71	1.15	1.15	0.46	1.50	0.35	0.12	1.50	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.38	12.73	5.17	0.66	0.53	0.53	0.27	0.13	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.26	17.29	11.21	0.27	0.81	0.81	0.27	0.00	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.52	12.66	4.84	0.43	0.43	0.85	0.85	0.00	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.48	6.26	13.50	0.33	1.65	1.65	0.33	1.32	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.16	10.24	2.35	0.69	2.21	0.28	1.38	0.14	0.55	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.85	8.73	1.75	0.70	1.05	0.70	0.35	0.00	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.66	4.70	2.86	0.00	2.25	1.22	0.20	0.41	1.84	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.82	7.19	7.91	1.44	0.72	0.72	0.00	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.90	5.07	5.69	0.41	3.21	0.93	0.52	0.10	0.41	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.80	5.02	0.91	0.23	1.14	0.91	0.68	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	12.59	15.10	5.03	0.84	1.68	0.42	1.26	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.08	8.82	5.23	0.30	1.34	0.75	1.05	0.30	1.20	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.68	6.91	4.73	0.26	1.75	1.31	0.35	0.18	0.70	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	24.30	13.25	0.37	0.00	3.68	1.47	0.37	0.00	2.21	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.31	15.74	7.73	0.57	2.29	0.29	0.57	0.29	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.84	50.10	2.11	1.68	0.84	0.42	0.42	0.00	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.98	4.11	5.94	2.74	0.91	1.37	0.46	0.46	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.32	6.91	5.37	5.12	1.02	1.28	0.00	0.00	1.79	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.20	4.45	5.76	3.93	0.79	0.79	0.00	0.00	1.57	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.95	3.08	4.93	2.77	0.92	1.54	0.31	0.00	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.12	4.71	6.35	3.53	1.18	2.35	0.47	0.00	1.65	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.00	5.42	8.80	4.74	1.69	1.35	0.00	0.00	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	19.26	5.50	6.68	4.32	0.79	1.57	0.00	0.00	3.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.93	4.63	6.49	3.71	0.46	1.85	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.73	7.79	7.50	5.19	1.15	3.17	0.29	0.29	3.46	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.32	6.02	9.15	4.02	1.78	0.67	0.00	0.22	0.89	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.07	3.12	6.97	4.09	1.20	3.36	0.24	0.00	2.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	2.93	4.40	5.87	0.73	0.73	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	2.01	5.03	4.36	1.34	0.67	0.67	0.34	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.70	4.91	6.96	3.68	1.23	2.05	0.00	0.00	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.36	3.44	5.15	5.15	1.72	1.72	0.00	0.43	1.72	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	5.47	2.73	0.00	0.00	2.73	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	5.16	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.44	2.92	6.50	5.52	0.97	1.95	0.00	0.65	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	4.36	1.45	2.91	1.45	2.91	0.00	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	5.86	4.80	2.67	1.07	2.67	0.00	0.53	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	5.72	4.09	3.27	0.00	4.09	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.27	3.50	6.22	3.50	1.55	0.00	0.00	0.39	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	6.30	6.30	6.30	0.00	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	0.99	0.99	0.00	0.99	0.00	0.00	0.00	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	1.19	2.37	1.78	0.59	0.59	1.19	1.19	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	1.22	7.31	2.44	0.00	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	6.97	2.53	2.53	0.00	1.27	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	24.14	2.76	3.79	3.45	2.07	2.07	0.34	0.34	2.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	6.45	0.00	6.45	0.00	0.00	0.00	0.00	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	7.98	0.00	3.99	3.99	0.00	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	10.33	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.85	2.44	4.48	3.26	0.81	1.22	0.41	0.00	1.22	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	1.59	3.97	6.36	0.00	0.00	0.00	0.00	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	2.36	8.25	5.31	0.00	0.59	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	6.55	4.36	7.17	0.31	1.25	0.00	0.00	2.18	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	4.01	4.01	8.02	1.34	2.67	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	2.37	7.10	15.37	0.00	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	5.14	0.00	2.57	0.00	2.57	0.00	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	4.13	6.20	7.57	0.00	2.75	0.00	0.00	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.24	4.45	15.83	8.91	0.00	0.49	0.00	0.99	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	2.24	15.70	3.36	0.00	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	8.90	15.27	5.72	0.64	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	4.43	21.76	4.03	0.00	0.81	0.00	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	6.54	21.81	0.00	0.00	2.18	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	3.80	20.27	2.53	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	11.53	3.03	16.99	4.25	0.61	0.00	0.61	1.21	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	9.04	27.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	3.29	13.18	3.29	0.82	0.00	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.46	4.76	6.35	6.15	0.00	1.39	0.00	0.00	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	16.87	4.87	6.81	9.09	0.00	0.65	0.00	0.32	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	6.11	6.11	7.13	0.00	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	2.32	2.32	3.09	2.32	1.55	0.00	0.00	2.32	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	5.91	10.39	7.32	0.00	1.18	0.00	0.71	0.71	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	12.28	14.36	1.39	0.00	1.39	0.00	2.32	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	4.27	0.00	0.00	0.00	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.84	19.73	2.77	0.41	0.31	0.21	1.03	0.10	0.62	0.31
mesothelioma cell line:Mero-25	10850-111F4	6.81	16.57	3.63	0.45	0.45	0.00	0.91	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	9.53	30.56	9.29	0.24	0.98	0.49	0.73	0.00	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	10.63	25.69	16.83	0.44	2.21	0.89	1.99	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	13.40	28.65	2.63	0.00	2.37	0.26	1.05	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	15.32	17.70	1.02	0.51	3.23	0.68	1.19	0.17	3.57	0.51
mesothelioma cell line:Mero-84	10855-111F9	8.59	31.85	7.33	0.00	1.26	0.25	1.26	0.00	1.26	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.74	13.87	5.80	1.24	4.76	1.24	1.45	0.41	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	8.12	41.74	4.64	0.17	0.33	0.83	1.82	0.99	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	1.99	22.80	1.81	0.00	0.00	0.00	1.81	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	12.30	29.89	12.47	0.34	1.71	1.20	2.22	0.17	2.73	0.68
mesothelioma cell line:NCI-H28	10845-111E8	13.74	20.36	2.54	0.00	0.51	0.25	2.04	0.25	0.51	0.00
mesothelioma cell line:No36	10857-111G2	4.57	23.81	2.94	0.33	0.65	0.33	2.94	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	7.32	23.84	5.15	0.27	1.63	1.08	0.54	0.54	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	51.44	26.10	33.01	1.34	3.26	1.34	0.96	2.11	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	26.13	14.65	42.74	0.85	1.83	0.98	0.98	1.71	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	31.77	10.95	24.05	1.08	3.41	1.08	0.54	0.54	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.08	22.20	9.14	0.65	4.90	1.96	0.98	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.72	11.66	2.97	0.21	0.42	0.64	0.85	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	2.99	23.96	11.29	0.00	0.46	0.00	6.91	0.46	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	8.37	19.98	16.37	0.57	0.19	0.38	0.95	0.00	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.00	55.44	5.17	0.00	0.00	0.00	2.59	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	24.71	16.21	46.85	0.00	2.57	0.40	2.17	0.00	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	10.15	30.44	0.51	0.51	1.01	2.03	1.01	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.44	55.12	8.04	0.20	0.78	1.37	1.77	0.39	1.37	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.46	12.81	0.89	0.11	2.23	0.00	2.67	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.02	14.41	2.21	0.22	2.13	0.07	2.35	0.51	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	12.14	8.83	5.52	0.00	3.31	0.00	1.66	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	51.53	68.56	0.00	4.37	3.22	3.91	1.61	3.68	2.07	2.07
neuroblastoma cell line:NB-1	10539-107G8	77.45	84.94	0.00	9.35	3.74	0.56	2.62	0.75	5.61	3.18
neuroblastoma cell line:NBsusSR	10607-108F4	30.16	48.72	0.00	7.38	2.95	3.59	2.32	0.84	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	116.47	133.61	0.19	15.09	4.47	2.05	0.93	8.94	7.45	3.54
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	52.19	37.01	0.00	8.07	3.80	4.51	0.71	0.47	1.19	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	61.93	36.59	0.00	4.12	4.43	1.43	0.32	0.63	1.74	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	44.48	60.18	0.20	11.47	2.21	3.02	2.21	0.00	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.34	29.25	0.00	0.64	0.00	0.64	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	20.23	3.73	0.80	0.53	0.80	0.53	0.00	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	39.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	28.41	75.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	66.46	223.92	0.00	25.54	6.26	1.35	1.52	0.68	5.24	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	9.61	16.81	0.80	0.00	2.40	2.40	8.81	0.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.78	8.02	7.05	4.49	2.56	1.28	0.32	0.64	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.39	7.36	21.81	3.42	1.31	1.58	0.26	0.79	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	40.87	20.15	3.66	11.81	6.28	7.41	6.09	9.56	3.84	5.34
occipital cortex - adult, donor10196	10172-103C1	18.54	26.78	0.00	10.30	6.18	12.36	4.12	16.48	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	36.50	23.88	5.10	13.95	7.78	14.76	1.34	20.66	5.10	6.71
occipital cortex, newborn, donor10223	10355-105E4	7.64	6.19	1.09	2.55	1.46	1.46	1.82	2.18	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	22.57	14.69	0.79	7.87	5.77	8.40	1.84	5.25	2.62	4.99
occipital lobe, fetal, donor1	10073-102A1	38.62	18.88	0.00	13.30	0.86	1.72	0.86	24.46	2.15	5.15
occipital pole, adult, pool1	10036-101E9	31.06	14.43	2.21	9.30	7.33	5.52	3.00	9.54	3.55	4.18
olfactory region, adult	10195-103E6	28.47	13.37	2.10	9.36	5.92	7.07	1.72	9.17	2.48	4.78
optic nerve, donor1	10277-104E7	40.02	14.01	2.00	28.01	8.00	26.01	0.00	18.01	0.00	16.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.46	29.84	24.49	0.00	0.00	0.00	6.38	0.23	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.56	59.21	0.82	0.00	0.27	0.14	14.01	0.82	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	48.26	65.36	8.13	0.68	11.01	2.88	8.30	0.34	1.52	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.67	53.94	2.89	0.00	1.85	0.12	4.39	0.69	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	16.76	14.70	6.47	0.00	2.65	0.88	1.18	0.88	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	18.69	0.00	0.00	0.93	0.93	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.57	17.60	2.54	10.39	4.03	0.85	0.00	0.64	1.48	0.00
ovary, adult, pool1	10020-101D2	78.44	14.50	3.67	17.03	2.62	5.07	0.70	5.94	2.62	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	3.85	13.93	2.02	0.18	1.10	0.73	1.47	0.37	0.00	0.18
pancreas, adult, donor1	10049-101G4	57.38	11.29	4.70	3.76	3.76	5.64	0.00	5.64	2.82	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	29.91	0.00	0.00	0.00	0.00	2.24	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	35.60	37.14	0.85	0.17	4.43	1.19	2.73	3.75	1.19	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.31	29.80	18.71	0.33	2.65	0.99	3.31	0.17	0.83	0.17
paracentral gyrus, adult, pool1	10035-101E8	33.86	17.94	2.38	7.87	5.86	6.86	3.66	7.60	2.20	4.94
parietal cortex, adult, donor10258	10373-105G4	22.75	13.21	0.73	6.61	4.40	2.20	0.00	7.34	1.47	2.94
parietal lobe - adult, donor10196	10171-103B9	18.81	17.87	0.94	6.58	2.82	11.29	1.88	12.23	2.82	7.52
parietal lobe, adult, donor10252	10157-103A4	35.91	23.66	3.99	12.26	3.71	8.55	2.85	15.11	4.28	4.28
parietal lobe, adult, pool1	10034-101E7	41.33	19.74	2.91	9.08	6.96	8.55	3.00	10.13	3.08	5.38
parietal lobe, fetal, donor1	10072-101I9	63.04	47.52	0.97	10.67	1.94	1.94	0.97	19.40	0.97	6.79
parietal lobe, newborn, donor10223	10356-105E5	14.95	10.09	2.99	3.74	2.24	0.75	0.00	4.11	0.00	1.50
parotid gland, adult	10199-103F1	32.68	9.87	9.25	5.55	4.93	7.40	6.17	1.85	0.62	1.23
penis, adult	10200-103F2	60.69	9.13	5.37	20.41	6.98	5.37	2.15	9.13	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	50.76	52.62	0.00	6.88	7.62	2.05	0.74	2.05	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	43.56	35.70	5.68	0.44	4.81	1.60	4.37	0.73	0.87	0.15
pineal gland - adult, donor10196	10179-103C8	20.00	27.74	9.68	25.16	3.87	4.52	1.29	5.81	5.81	0.65
pineal gland, adult, donor10252	10160-103A7	62.18	33.16	9.48	61.59	14.81	10.07	1.18	11.25	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	29.47	11.91	11.29	70.86	8.78	6.90	3.14	2.51	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	54.64	27.32	1.01	15.18	8.09	4.05	4.05	1.01	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	113.10	21.89	3.65	18.24	8.86	14.07	3.65	7.82	10.94	2.08
pituitary gland, adult, donor10258	10378-105G9	74.06	19.58	0.00	21.28	7.66	9.36	11.92	0.85	3.40	1.70
placenta, adult, pool1	10021-101D3	31.93	21.61	12.15	6.02	1.83	0.97	2.58	7.74	0.43	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	8.61	32.31	1.46	0.40	0.40	0.79	1.72	0.26	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	55.72	40.15	18.05	7.63	11.83	6.23	1.40	2.80	5.14	1.87
pons, adult, pool1	10033-101E6	35.98	14.37	5.25	8.35	5.25	4.73	3.10	7.40	3.61	6.20
postcentral gyrus, adult, pool1	10032-101E5	36.44	15.60	2.35	8.63	7.93	6.71	3.14	8.72	3.14	4.36
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	33.46	2.09	0.00	0.00	0.00	4.18	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	11.02	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	12.67	27.24	8.01	0.00	1.75	0.00	7.14	0.58	0.58	0.00
prostate cancer cell line:PC-3	10439-106E7	23.41	40.29	1.45	0.73	1.27	1.09	5.81	0.73	2.36	0.54
prostate, adult, pool1	10022-101D4	60.04	24.03	17.87	24.94	5.35	7.80	1.45	6.80	3.72	1.63
putamen, adult, donor10196	10176-103C5	32.10	21.25	2.60	10.39	4.49	7.55	11.33	6.61	4.25	4.01
putamen, adult, donor10252	10152-102I8	15.69	13.73	7.84	5.88	1.96	1.96	3.92	11.76	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	24.04	0.00	6.56	0.00	1.09	7.65	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	20.05	12.56	0.97	9.66	1.69	5.32	6.52	4.59	1.45	0.48
putamen, newborn, donor10223	10365-105F5	31.49	9.00	9.75	8.25	2.25	0.00	0.75	1.50	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	3.49	48.00	4.07	0.00	0.00	0.00	5.24	0.58	0.00	0.00
rectum, fetal, donor1	10067-101I4	63.99	34.77	2.78	16.69	1.39	1.39	2.78	4.17	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.51	18.87	7.42	0.00	0.21	0.00	1.91	0.21	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.68	30.65	4.97	0.00	7.46	0.41	2.07	2.07	2.49	0.00
retina, adult, pool1	10030-101E3	64.21	21.67	13.52	40.06	14.21	7.06	1.19	11.33	2.68	2.48
retinoblastoma cell line:Y79	10475-106I7	24.16	82.10	0.00	16.37	2.86	0.00	9.35	0.52	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	14.75	29.88	0.00	0.25	1.11	0.37	4.18	0.12	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.68	54.27	0.00	14.62	1.69	0.28	0.28	0.84	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	6.82	6.06	17.43	0.76	0.76	0.00	0.76	6.06	1.52
salivary acinar cells, donor1	11771-123I7	11.98	11.17	3.40	1.94	4.86	0.65	0.49	0.16	0.81	0.16
salivary acinar cells, donor2	11772-123I8	27.81	15.56	6.06	4.13	10.46	1.93	1.10	0.83	2.62	0.41
salivary acinar cells, donor3	11773-123I9	16.55	13.24	3.31	5.30	9.93	3.31	2.65	0.00	4.63	1.32
salivary gland, adult, pool1	10093-102C3	31.46	24.02	24.02	12.01	6.86	13.73	4.58	2.86	1.14	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	21.58	29.17	33.64	0.17	0.51	0.25	1.18	0.00	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	17.75	29.04	25.63	0.24	0.59	0.47	1.06	0.24	0.59	0.00
seminal vesicle, adult	10201-103F3	69.84	21.16	20.63	10.58	5.29	7.94	5.29	4.23	3.70	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.61	38.14	2.67	1.46	3.40	1.70	1.21	1.46	2.43	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.09	11.58	5.28	0.00	1.26	0.25	0.75	1.01	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	29.10	2.01	0.00	0.00	0.00	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.91	9.94	3.49	2.55	1.07	1.48	1.48	3.36	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	14.48	62.89	2.10	0.88	1.55	0.44	6.96	0.44	0.11	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.16	36.77	3.23	0.26	2.58	0.90	3.48	0.26	3.48	1.29
skeletal muscle - soleus muscle, donor1	10282-104F3	24.83	3.55	7.80	12.06	6.38	7.80	0.00	3.55	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	45.82	4.80	2.76	12.11	7.80	5.16	0.60	8.52	2.04	1.44
skeletal muscle, fetal, donor1	10066-101I3	81.41	10.05	2.01	28.14	0.00	5.03	0.00	4.02	2.01	2.01
skin, adult, donor1	10074-102A2	88.21	6.79	0.00	6.79	0.00	6.79	0.00	13.57	0.00	20.36
skin, fetal, donor1	10065-101I2	76.38	17.67	5.68	15.15	5.05	4.42	1.26	1.89	1.89	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	11.34	55.36	0.67	0.67	0.67	1.67	9.01	0.67	2.67	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	69.35	95.19	0.00	25.85	10.40	3.78	8.20	3.78	12.61	2.84
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.59	16.00	0.00	1.54	0.96	0.77	0.39	4.43	1.16	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	36.26	66.92	1.81	1.15	10.55	1.32	13.02	1.15	2.97	1.48
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.29	73.35	0.00	8.20	1.13	0.00	1.45	4.99	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.31	86.95	10.24	20.05	13.29	5.45	15.91	1.31	3.49	1.53
small intestine, adult, pool1	10024-101D6	86.95	14.09	3.58	5.61	4.90	2.15	2.39	4.30	1.79	1.91
small intestine, fetal, donor1	10064-101I1	56.76	16.95	0.25	8.11	3.44	1.23	1.47	3.19	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	13.85	29.24	1.03	1.54	4.62	2.05	8.21	1.54	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	36.70	13.70	25.33	26.36	6.72	11.11	0.26	7.24	4.91	3.36
somatostatinoma cell line:QGP-1	10781-110G7	8.31	14.74	16.08	0.80	3.48	5.09	10.18	1.61	2.41	0.54
spinal cord - adult, donor10196	10181-103D1	27.30	9.41	3.44	8.95	2.75	4.59	0.69	9.64	2.75	6.65
spinal cord, adult, donor10252	10159-103A6	57.17	13.41	11.04	12.22	5.52	7.89	0.39	12.22	8.67	13.41
spinal cord, adult, donor10258	10369-105F9	29.75	12.45	8.99	15.22	2.08	5.53	1.38	5.53	1.38	4.84
spinal cord, fetal, donor1	10056-101H2	35.98	9.15	0.00	11.59	1.22	3.05	0.00	5.49	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	39.03	21.58	13.32	11.94	4.13	2.76	0.46	7.81	2.76	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.95	11.80	7.02	0.90	1.19	1.34	0.90	0.30	0.30	0.00
spleen, adult, pool1	10025-101D7	40.31	13.33	5.62	1.43	2.64	4.74	0.77	1.87	1.43	0.33
spleen, fetal, pool1	10044-101F8	71.83	26.46	6.83	6.36	2.38	4.85	1.03	4.53	1.99	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.46	21.53	8.28	0.10	0.21	0.21	2.79	0.31	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.39	22.22	8.92	0.19	2.47	0.76	5.13	0.76	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.22	41.58	3.15	1.40	2.80	0.00	5.59	1.75	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	15.25	3.13	0.39	0.78	0.78	2.35	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	62.47	25.10	34.44	1.01	4.84	2.25	11.14	2.93	1.69	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	24.57	0.00	0.42	0.42	1.69	1.69	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	56.27	2.54	0.00	0.85	0.42	1.27	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	26.70	19.22	4.27	9.61	0.00	1.07	1.07	2.14	4.27	0.00
submaxillary gland, adult	10202-103F4	30.19	14.24	10.82	7.41	5.13	3.42	2.28	3.99	2.28	1.71
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00	54.27	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	47.15	17.24	6.23	14.54	6.02	11.01	0.00	22.43	12.88	18.28
substantia nigra, adult, donor10258	10371-105G2	16.55	13.45	1.03	7.76	2.59	6.72	2.07	5.69	2.07	1.55
substantia nigra, newborn, donor10223	10358-105E7	24.73	13.42	5.65	11.31	3.53	6.36	0.71	4.95	2.12	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	22.70	38.29	0.00	2.06	1.60	0.69	3.21	0.92	1.83	0.69
temporal lobe, adult, pool1	10031-101E4	38.06	20.09	2.71	11.36	7.63	6.53	3.48	8.31	4.15	5.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.25	27.07	0.71	10.68	0.71	2.14	4.99	19.94	5.70	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	45.71	33.84	0.88	17.58	1.32	2.64	3.52	21.98	3.08	3.96
tenocyte, donor1	11763-123H8	30.02	9.77	9.77	5.24	1.05	1.75	0.00	0.70	0.70	0.00
tenocyte, donor2	11765-123I1	28.23	1.91	9.54	7.63	0.76	3.43	0.00	0.00	1.53	1.91
tenocyte, donor3	11768-123I4	19.27	5.19	2.97	1.11	0.00	1.11	0.00	0.00	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.06	44.36	0.51	2.21	0.00	0.17	0.68	0.68	0.85	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	7.86	41.16	0.00	5.24	0.92	0.46	0.31	0.62	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	3.25	45.72	0.93	1.39	0.46	0.15	3.10	1.86	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1.52	22.09	0.76	0.13	0.00	0.00	2.29	3.94	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.72	32.14	0.00	0.76	0.38	0.38	0.38	7.19	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.11	20.61	0.00	0.00	0.00	0.00	1.53	6.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.00	35.18	0.00	0.00	0.00	0.00	3.26	3.58	0.00	0.00
testis, adult, pool1	10026-101D8	54.55	16.96	5.37	9.66	2.90	2.68	3.44	5.48	3.33	2.04
testis, adult, pool2	10096-102C6	50.52	50.97	4.51	8.12	3.16	4.51	12.63	11.73	4.06	2.26
thalamus - adult, donor10196	10168-103B6	20.98	14.35	2.21	15.46	3.31	14.35	1.10	8.83	5.52	3.31
thalamus, adult, donor10252	10154-103A1	50.95	18.75	5.78	29.22	8.13	17.35	0.94	20.00	9.53	12.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	43.11	18.48	1.54	21.55	0.00	18.48	0.00	1.54	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.09	8.56	2.47	8.40	1.15	4.45	1.81	5.60	1.48	2.14
thalamus, newborn, donor10223	10366-105F6	5.18	2.88	2.30	1.15	1.15	0.58	1.73	1.15	1.15	0.00
throat, adult	10209-103G2	45.44	18.48	6.74	7.49	4.49	5.99	3.00	5.99	2.00	1.00
throat, fetal, donor1	10061-101H7	63.38	18.59	7.31	15.84	1.83	6.09	2.74	2.44	2.13	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	30.21	49.48	0.00	2.78	3.97	2.98	5.76	0.20	0.79	0.99
thymus, adult, pool1	10027-101D9	67.50	45.53	2.09	5.57	2.78	7.46	2.88	0.89	1.59	0.50
thymus, fetal, pool1	10043-101F7	79.49	55.07	3.64	8.31	4.16	7.90	2.60	2.08	2.81	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	4.25	36.83	6.25	0.00	1.20	0.00	1.73	0.66	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	28.78	54.48	9.50	0.56	2.10	1.40	2.37	0.84	2.24	0.28
thyroid, adult, pool1	10028-101E1	76.61	14.65	4.29	5.88	6.07	7.93	2.80	5.41	2.89	1.21
thyroid, fetal, donor1	10060-101H6	59.32	13.71	16.08	9.49	4.48	7.12	5.27	2.90	1.58	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	15.40	15.40	12.32	0.00	3.08	0.00	12.32	0.00	3.08
tongue, adult	10203-103F5	30.47	15.12	5.81	5.12	2.33	2.79	1.16	3.49	1.16	1.63
tongue, fetal, donor1	10059-101H5	37.04	11.82	3.15	7.49	3.15	3.55	0.39	4.34	0.79	0.79
tonsil, adult, pool1	10047-101G2	55.80	36.06	14.53	3.91	3.61	8.11	5.11	1.80	1.20	0.70
trachea, adult, pool1	10029-101E2	35.91	12.52	9.57	4.50	3.27	3.76	3.27	1.80	1.06	0.98
trachea, fetal, donor1	10058-101H4	32.31	12.31	1.92	19.62	2.31	4.62	1.54	4.62	1.92	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.23	10.27	10.27	2.13	1.06	1.42	0.71	0.00	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	21.78	46.30	1.72	0.81	0.81	0.41	7.80	0.30	0.41	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	29.61	51.39	40.43	0.94	2.35	1.10	2.19	0.31	0.78	0.16
tridermal teratoma cell line:HGRT	10694-109G1	15.22	9.51	0.00	1.90	3.81	3.81	0.00	0.00	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	51.04	11.17	9.48	0.76	4.66	2.62	1.19	0.93	1.95	0.17
umbilical cord, fetal, donor1	10057-101H3	35.47	8.35	0.00	18.78	0.00	4.17	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	115.69	24.06	31.57	33.96	10.41	15.87	1.37	11.94	9.04	3.41
uterus, fetal, donor1	10055-101H1	54.78	18.94	4.61	23.55	4.61	3.58	1.54	3.58	1.54	1.02
vagina, adult	10204-103F6	26.49	9.69	7.75	21.97	1.94	10.99	0.00	6.46	2.58	2.58
vein, adult	10191-103E2	46.03	14.91	6.58	6.14	3.95	7.45	0.44	3.07	1.75	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.48	9.35	12.02	0.27	0.00	0.27	1.07	0.00	0.27	0.00